EMERGING MEDICAL TECHNOLOGIES® SPOTLIGHT

• Online Database
• PDF
• eBook

• Search by Keyword/Market (e.g., heart valve, orthopedics, etc.)
• Search by Company Name

The Online Database Format Includes Advanced Searching:

Keyword & Exact Phrase Searching:		Search By Medical Market:
Search By Conference:		Search By Company Name:
Search By Region:

Technology descriptions for companies currently covered as of 01/31/12 include:

• Company 1 - Proprietary technology for decellularizing biological organs/tissues to create an extra-cellular matrix retaining its original architecture, mechanical properties, and vascular network - suitable for scaffold transplantation or growing new functional organs/tissues by recellularization
• Company 2 - The MediGLIDER is a battery-powered device which lifts and acquires a healthcare patient weighing up to 500 lbs. - without any caregiver's touching, logrolling, or lifting - and transports them to the next destination, then gently discharges them onto the desired horizontal surface
• Company 3 - The patented EXMI technology uses pulsed magnetic fields that penetrate up to 7,5 cm into the body, stimulating nerves (neuromodulation), contracting muscles (rehabilitation), treating pain/depression, and increasing blood flow
• Company 4 - Requiring only one drop of blood, the proprietary LBIdx(TM) Plasma Thermogram(TM) tests will significantly improve the clinical diagnosis and monitoring of autoimmune disease and cancer, vastly improving patient outcomes
• Company 5 - Genable Technologies is a venture-backed bio-pharmaceutical company developing new gene-based medicines to treat "dominant" genetic diseases, particularly for the eye
• Company 6 - DiagnOptics' technology provides an immediate cardiovascular risk prediction for major chronic diseases, such as diabetes. The method is convenient, easy-to-use, and validated. It measures tissue accumulation of Advanced Glycation End products (AGEs) by means of fluorescence techniques. AGEs play a key role in the pathogenesis of many age-related diseases, such as diabetes and cardiovascular disease.
• Company 7 - An oral delivery platform for medications, food supplements, and other soluble substances that is easy-to-use, friendly, inexpensive, and requires no third-party assistance
• Company 8 - Ventritek 105 is a novel medical device that provides full treatment for Stroke/SAH/ICH patients by replacing the current long and risky procedure
• Company 9 - An inhaler with variable dosage of Asthma medicine, based on a built-in exhaling measurement of the airway obstruction level
• Company 10 - American Radiosurgery, Inc. produces the RGS Vertex360(TM), which competes with the Gamma knife in the non-invasive treatment of brain tumors. This highly precise cobalt 60 radiation system utilizes the OsiriX(TM) based Explorer 4D(TM) treatment planning system, also developed by American Radiosurgery, Inc.
• Company 11 - Allon Therapeutics Inc. is a clinical-stage biotechnology company focused on bringing to market innovative central nervous system therapies. Allon is proceeding in a fully enrolled pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP).
• Company 12 - Vaccine platform technology for cancer and infectious diseases based on Listeria monocytogenes that has been engineered to be safe for use in humans and express and specific disease antigens
• Company 13 - Real-time, non-contact, high resolution tissue temperature monitoring & mapping products that improve the safety and efficacy of ablation therapy by avoiding injury to surrounding tissue
• Company 14 - Oncology drugs that utilize novel mechanisms of action
• Company 15 - Electronic stimulation technologies that maintain muscle strength during recovery in the intensive care unit or other periods of inactivity
• Company 16 - The fentanyl iontophoretic transdermal system (IONSYS), an investigational, pre-programmed drug delivery system comprising a compact, needle-free, self-contained system that provides patient-controlled analgesia for adult inpatients requiring post-operative opioid therapy
• Company 17 - Two novel technologies that boost immune responses, including a synthetic toll-like receptor agonist for use as an adjuvant to vaccines , and a viral vector that targets immature dendritic cells
• Company 18 - A molecular diagnostics test that examines somatic alterations in cancer-related genes by applying massively parallel sequencing to routine clinical specimens, enabling targeted therapy
• Company 19 - Nanofibers designed for use in tissue engineering, drug delivery, and wound care
• Company 20 - Vascular closure device that seals the femoral artery following cardiac catherization
• Company 21 - An aerosolized long-acting muscarinic antagonist that treats chronic obstructive pulmonary disease (COPD)
• Company 22 - Novel metal abstraction peptide (MAP) platform technology that delivers platinum to cancer cells by incorporating it into cancer-targeting proteins, thereby improving treatment while limiting side effects and damage to healthy cells
• Company 23 - Long-acting, intravenous lipoglycopeptide used to treat acute bacterial skin and skin structure infections
• Company 24 - Innovative new topical therapies for dermatology applications, including photodynamic therapy for sebaceous gland disorders and small molecule therapeutics that treat acne, inflammatory skin diseases, and sebaceous gland hyperactivity
• Company 25 - Novel, minimally invasive surgical devices for the treatment of sinusitis
• Company 26 - Novel drugs that treat cancer by targeting cellular protein homeostasis pathways
• Company 27 - A next-generation eye drop medication that uses Rho-kinase inhibitors to treat glaucoma
• Company 28 - Minimally invasive spinal disc regeneration technologies (SRTs) with a goal of biologically regenerating the tissues of the disc to restore the natural visco-elastic, biomechanical, and fluid characteristics of the inner core and outer tensil ring
• Company 29 - MedApps' solutions utilize cloud computing to connect patients and professional care providers, enabling proactive healthcare delivery
• Company 30 - Novel 3D cell culture devices for stem cell, tissue engineering, cancer, and drug discovery applications
• Company 31 - Developing a whole-plant therapeutic, AMZ0026, that exhibits immunomodulator properties for the treatment of HIV/AIDS. Preliminary clinical studies in patients that are seropositive for HIV-1 have demonstrated a positive effect on CD4 and CD4/CD8 blood serum levels.
• Company 32 - A Leptin product as a novel hormone replacement therapy for Alzheimer's disease (AD) and/or as a preventative for those who are at risk
• Company 33 - EMMA (Electronic Medication Management Assistant) - a remote medication administration unit that is placed in a patient's residence to enable a healthcare professional (i.e., pharmacist or nurse) to remotely administer their oral medications
• Company 34 - A disruptive next-generation low profile (14 French), pre-mounted and pre-packaged "package-to-patient" percutaneous Transcatheter Heart Valve (THV)
• Company 35 - EPIFLO utilizes cutting-edge oxygen concentration technology to create tissue regenerative processes driving closure of delayed-healing acute or chronic wounds
• Company 36 - Drugs to treat dry Age Related Macular Degeneration (dAMD) and other vascular diseases of the eye, including Glaucoma, DME, and Diabetic Retinopathy
• Company 37 - Endoluminal device for incisionless treatment of obesity
• Company 38 - Software that can read and analyze the image stack of a CT scan and draft a report that includes major pathological findings, identification of key images, and quantitative measurements - provided to the radiologist at the customers site
• Company 39 - Developer of easy-to-use genetic tests (clinically validated DNA SNP patterns) that empower individuals to prevent certain chronic conditions and manage their existing health and wellness through actionable guidance
• Company 40 - A therapeutic for HIV that is divergent from current approaches, in that rather than fight against HIV's greatest strengths - mutation frequency & rate of replication - the drug exploits these "strengths" to cause viral population collapse
• Company 41 - A device that uses non-invasive ultrasound to disrupt the blood-brain barrier, for delivery of large molecule therapeutics to treat primary and metastatic brain tumors
• Company 42 - The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology, and molecular genetic testing
• Company 43 - Developing healthier drugs from whole-plants. MAHDL, developed to elevate HDL-C, has undergone tests in man with positive results and has an IND from the FDA. Other whole-plant therapeutics are under development for dementia.
• Company 44 - ZeroFold, the lowest profile balloon available for improving deliverability and effectiveness of balloon angioplasty catheters
• Company 45 - A revolutionary technology to sterilize proteins in dehydrated formulations by irradiation (beta, gamma) or Ethylene Oxide
• Company 46 - Next-generation vaccines based on patented LAMP Technology that induce a strong and complete immune response, with applications in allergy, cancer, and infectious disease
• Company 47 - The world's first homozygous parthenogenetic stem cell lines that can provide therapeutic cells with the potential to be transplanted into hundreds of millions of individuals of differing ages and racial backgrounds with minimal risk of immune rejection
• Company 48 - A web-enabled, low level electromagnetic therapy system, that provides HealthCare providers in the Complementary and Alternative Medicine (CAM) marketplace with a device that improves both their Patients' Health and their Business
• Company 49 - Bioluminescent (light producing) proteins and related substrates that can: 1-be used as an adjunct to surgery, including laparoscopy, 2-track the progression of disease and evaluate the effectiveness of therapy, and 3-diagnosis a disease process before there are symptoms or anatomical features such as tumors
• Company 50 - A patented ultrasound miniaturization technology which has enabled the creation of iPod sized ultrasound pain therapy systems with unprecedented operation times of up to 6 hours on a single cell phone battery
• Company 51 - Miniaturized, hand-held, instrument-mounted optical measurement and navigation systems for surgical applications
• Company 52 - Turnkey SaaS software solution that dramatically reduces errors, turnaround times, and costs of MRI, CT, and PET-CT diagnostic reports
• Company 53 - Fast-track development of novel drugs for an unmet medical need - Alzheimer's disease - with rapid payback on investment
• Company 54 - Technology platforms that improve surgical efficiency in complex orthopedic procedures such as total joint replacement, spinal fusion, and trauma fixation: 1-For medical device manufacturers, RepAssist(TM) reduces training costs, dramatically compresses the time it takes for new reps to provide value in the OR, and enhances rep efficiency with existing accounts. 2-For hospitals/surgery centers, Virtual Backtable(TM) significantly enhances OR team proficiency in organizing and utilizing instrumentation, independent of the team's experience level with the implant system or surgeon, resulting in improved surgical efficiency and higher surgeon satisfaction.
• Company 55 - Implantable devices that allow surgeons to reduce the morbidity of spinal deformity surgery with a procedure that is quicker, safer, and more cost-effective than existing techniques
• Company 56 - Minimally invasive, joint preserving treatment option for chronic knee osteoarthritis (OA) pain; an alternative to total knee replacement (TKR)
• Company 57 - A broad platform of minimally invasive intramedullary devices to improve fracture fixation, reduce soft tissue trauma, and speed the patient's return to normal daily activities
• Company 58 - Intra-articular ion channel modulators for the treatment of osteoarthritis (OA) in all synovial joints
• Company 59 - A breakthrough platform technology that provides highly porous (>65%), load-bearing orthopedic implants in both surface active (metal, ceramic) and resorbable materials
• Company 60 - An easy-to-use, low-cost, point-of-care (POC) ELISA-based adjunctive screening kit, specifically for oral cancer
• Company 61 - A neurostimulation technology to improve function and independence after stroke
• Company 62 - A simplified, ultra-sensitive, and dynamic platform for point-of-care (POC) diagnostics that is capable of direct sample-signal amplification diagnostics in low-cost, rapid lateral flow, and hand-held cartridges in both single and multiple test formats
• Company 63 - Hand-held smart drill with robotic technology that provides: safe depth control, accurate depth measurement, bone density measurement, and performance feedback for orthopedic and spine applications
• Company 64 - An affordable drug delivery pump/patch that is cost-competitive with pre-filled pen injectors and offers a superior end-user experience
• Company 65 - A disruptive, non-invasive, and long-term neuro-monitoring technology with the potential to reduce stroke and damage from aneurysms, tumors, and other neurologic trauma
• Company 66 - A minimally invasive stent platform that offers safe, simple, and accelerated healing for the treatment of endoluminal diseases
• Company 67 - MGI Medical's "Pulse Flowmeter" provides sensitive, early detection of hemodynamic instability through continuous, non-invasive assessment of peripheral blood flow. This permits early detection and management of blood loss and/or heart failure when there have been no changes in vital signs.
• Company 68 - An ultrasensitive hand-held probe that is capable of detecting specialized, subcutaneously injected magnetic materials and is used to locate lymph nodes to support the diagnosis and treatment of cancer
• Company 69 - A non-invasive, accurate, and easy-to-use female fertility monitor
• Company 70 - A low-cost incision guide that is applied with an adhesive sticker before a medical scan and leaves behind an ink imprint of locational markings (such as a grid or ruler) on the patient's skin so that the surgeon can accurately correlate target locations with the medical image
• Company 71 - Technology that enables and facilitates seamless stenting of all coronary bifurcation disease scenarios
• Company 72 - A biopharmaceutical company with an extensive library of structurally diverse bioactive peptides with broad applications in the health, beauty, and pharmaceutical industries
• Company 73 - 1-A spray drying technology to enable the storage of plasma in diverse environments by methods that are far simpler/less costly than those used currently and 2-A product to enable platelets to be stored in refrigerators rather than at room temperature to: (i) improve safety, (ii) extend shelf life, and (iii) significantly reduce costs
• Company 74 - A mechanical thrombectomy kit that will help restore blood flow and reduce hemorrhagic complications associated with acute ischemic stroke therapy
• Company 75 - Miniature infrared thermal imaging cameras combined with a spectroscopic infrared real-time in vivo analysis device for the early detection/accurate identification of internal lesions and tumors, as an add-on to existing endoscopes
• Company 76 - A unique lipid-soluble anti-oxidant heavy metal chelator that is safe and effective, for which the company is pursuing orphan drug approval
• Company 77 - ImplantLock, a device that enables a safe alternative to vertical bone augmentation or sinus lifting as well as immediate functional loading even after tooth extraction
• Company 78 - Advanced medical technology that combines CO2 laser capabilities with autologous stem cells to significantly improve cardiac output in patients with heart disease or heart failure
• Company 79 - A take-home conception aid system that is designed to address the growing unmet need of delayed/unsuccessful natural fertility that historically has had similar results to intrauterine insemination (IUI), yet can now be done in the privacy of the home
• Company 80 - Integrated molecular diagnostic system that is easy to use and requires little or no training
• Company 81 - Technologies that: 1-Temporarily plug body passageways with a thermo-transitioning gel that is delivered as a cold liquid, solidifies at body temperature, and is later flushed away and 2-Keep body passageways open with gentle passively dilating devices, as well with more rigid construction of an open design, to prevent eventual long-term blockage
• Company 82 - Non-invasive disposable device to automatically deliver a new therapy called *Remote Ischemic Preconditioning*, an adjunct to traditional treatments for heart attack and stroke that mitigates ischemia-reperfusion injury and has been clinically shown to reduce infarct size by 50%, without side effects
• Company 83 - Biologically compatible polymers that provide non-surgical regenerative therapies for treating chronic and acute episodes of pain
• Company 84 - The only device-based therapy, offering low-cost and non-invasive treatment for a wide range of antenatal conditions; thereby promising to prevent preterm birth
• Company 85 - The first miniature and highly accurate guide for brain surgery that is fully MRI-compatible and gives the possibility to perform simultaneous bilateral procedures, in addition to being easy-to-use and cost-effective
• Company 86 - A hand-held device with a touch-screen interface that identifies a patient's preferred language and then collects his/her information, medical history, symptoms, and complaints, which are then summarized into the caregiver's language and can be accessed on the device/through a facility's electronic health records (EHR) system
• Company 87 - Innovative single-use surgical retractors designed to manage all MIS exposure needs in gynecological, digestive, visceral, and vascular surgery
• Company 88 - Small, discrete, and disposable device to reduce food intake
• Company 89 - Cartilage repair using cell therapy - true, 100% hyaline cartilage tissue, in a single procedure, using an off-the-shelf product
• Company 90 - X-ray light valve device for use in conjunction with mammography screening and future imaging modalities
• Company 91 - Genetic test for expectant mothers that detects spina bifida
• Company 92 - Hand-held, disposable device that transdermally removes spider and reticular veins without a sclerotherapy agent
• Company 93 - Needle-free silicone patch for vaccine delivery
• Company 94 - Next-generation PCR system that can provide absolute quantification of nucleic acid molecules, at higher resolution and lower target levels than the current standard, thereby identifying diseases earlier in progression
• Company 95 - Minimally invasive protostatic reshaping device for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH)
• Company 96 - Immediate detection and identification of bacteria in bodily fluids through optical spectroscopy with low quantities of material without bacteria culturing
• Company 97 - Temporary implantable ventricular assist device (VAD) that wraps around the heart and squeezes it to help pump blood
• Company 98 - Non-invasive nitric oxide gas (gNO) technology and iontophoresis drug delivery for treating diseases of the skin and nails
• Company 99 - Immunomagnetic cell capture system which isolates and removes pathogens directly from the blood in under 30 minutes
• Company 100 - Synthetic 3D extracellular matrices to support tissue growth for use in a wide range of regenerative medicine
• Company 101 - Small molecule plasma kallikrein inhibitors for the treatment of diabetic macular edema (DME)
• Company 102 - Prefilled, easy-to-carry epinephrine auto-injection device for people with severe allergies
• Company 103 - Micro-needle skin patch for delivery of the influenza vaccine
• Company 104 - Hand-held device that sublingually monitors changes in carbon dioxide (CO2) levels for the prevention of septic shock
• Company 105 - Minimally invasive memory polymer devices for use in peripheral vascular, non-vascular, and neurovascular applications
• Company 106 - Energy-based thermal surgery device that provides better soft tissue cutting and coagulation
• Company 107 - Aerosol-based inhaled insulin delivery device
• Company 108 - Flexible patch applied over the neck that uses light wavelengths to produce and control the production of nitric oxide (NO) in vascular tissue leading to the brain, for the treatment of Alzheimer's and other neurological disorders
• Company 109 - Implantable, wireless, intracranial pressure monitor for use in patients with tumors, prior strokes, and traumatic brain injuries (TBI)
• Company 110 - Self-expanding, fully removable, temporary inferior vena cava (IVC) filter used in conjunction with the placement of a central line for the prevention of pulmonary embolism
• Company 111 - Fine-needle aspiration system for use in interventional endoscopic procedures
• Company 112 - Low-cost mobile device and software that adapts smartphones into ECG machines
• Company 113 - Unit-dose, prefilled, room-temperature stable vaccine reconstitution and delivery device
• Company 114 - Electrophysiological mapping device for the treatment of complex cardiac arrhythmias
• Company 115 - Hand-held, non-contact vein illumination device for imaging veins just below the surface of the skin
• Company 116 - Miniaturized, continuously adaptable, left ventricular assist device (LVAD) for the treatment of heart failure
• Company 117 - Drugs to treat breast and other cancers by targeting cancer stem cells
• Company 118 - Real-time vital signs monitoring with data collected from earbuds and streamed wirelessly to mobile devices or the web for viewing
• Company 119 - Drug therapy for the treatment of rare diseases such as hereditary inclusion body myopathy (HIBM)
• Company 120 - Compounds for oncology indications, including: 1-the prevention of A) chemotherapy-induced nausea and vomiting (CINV), B) post-operative nausea and vomiting (PONV), and C) chronic cough and 2-treatment for patients with non-small cell lung cancer (NSCLC) whose tumors express an Anaplastic Lymphoma Kinase (ALK) fusion protein
• Company 121 - Portable, self-contained system for the precise minimally invasive removal of diseased tissue, to restore natural tendon and soft tissue function in the elbow, knee, ankle, foot, and shoulder
• Company 122 - Thermal pulsation system for effective, in-office treatment of evaporative dry eye
• Company 123 - Non-invasive neuromodulation device that exposes the brain to an oscillating magnetic field, for the treatment of psychiatric and neurological disorders such as major depressive disorder and bipolar depression
• Company 124 - Real-time orthopedic surgery imaging system that will save valuable time for surgeons and hospitals, while improving surgery accuracy and patient safety
• Company 125 - An interactive, computer-assisted system utilizing image-guided robotics to enhance the quality of hair follicle harvesting during hair restoration surgery
• Company 126 - Wireless, non-invasive, and portable brainwave recording device for convenient at-home sleep monitoring and analysis to: 1-offer insight into the diagnosis and treatment of conditions such as Alzheimer's, autism, cancer, epilepsy, depression, and schizophrenia and 2-reveal how drugs affect the brain
• Company 127 - Subcutaneously implanted drug delivery device for slow and consistent release of therapeutic agents over a period of weeks or months, as an alternative to current treatments with a long regimen of injections and/or clinical visits
• Company 128 - Non-invasive device to alleviate the symptoms of subjective tinnitus that synchronously presents sound using headphones and tactile representations to an intra-oral array on the tongue
• Company 129 - A family of single-use devices that provide quantitative pressure measurements, while alleviating doubt and uncertainty during common medical procedures such as central line insertions, spinal taps, and epidurals
• Company 130 - Ozone injection system for multiple spinal applications, including herniated disc, to eliminate the need for multiple steroid injections and/or a surgical discectomy
• Company 131 - Bone anchorage technology for use in spine, trauma, and general orthopedics
• Company 132 - Non-systemically absorbed compounds for the treatment of diabetes and obesity, as an alternative to gastric bypass surgery
• Company 133 - Diagnostic tests that leverage the ability to extract clinically relevant information from maternal blood, including a non-invasive prenatal test to diagnose specific genetic and other inherited disorders
• Company 134 - Regenerative stem cell therapy to treat heart failure (HF), acute myocardial infarction (MI), angina, peripheral artery disease (PAD), and hard-to-heal wounds including burns, diabetic foot ulcers, venous stasis ulcers, and pressure ulcers
• Company 135 - A non-invasive hand-held system for accurately measuring circulating blood volume in real-time, to quickly identify and treat shock
• Company 136 - Device used to safely deliver epidural anesthesia during childbirth and other procedures
• Company 137 - Implantable neurostimulation device for the treatment of obstructive sleep apnea (OSA)
• Company 138 - Superior nasal drug delivery that can increase therapeutic drug concentrations in the brain and lower drug concentrations in the blood
• Company 139 - Pancreatic islet cell transplantation as a potential cure for Type I diabetes
• Company 140 - Liver dialysis system that removes protein-bound toxins plus water-soluble toxins from blood and is more effective and cost-efficient than currently available therapies
• Company 141 - System that is capable of simultaneous quantitative and independent determination of up to 100 biomarkers in individual cells, not possible with existing technologies, for early disease diagnosis and monitoring of treatment efficacy
• Company 142 - Molecular testing that analyzes gene expression in airway epithelial cells to detect early signs of lung cancer
• Company 143 - Biocompatible surgical mesh with high tensile stiffness and strength, similar to native tendon, that is sutured over torn or degenerative tissue as a reinforcement to surgical repair to allow for rapid tissue in-growth
• Company 144 - Next-generation quantitative angiography
• Company 145 - A "smart shirt" that can count a patient's heartbeats through its sensors, record a medical quality electrocardiogram (ECG), and detect the respiration rate, body temperature, and position of the patient (standing, walking, lying, asleep, or fallen)
• Company 146 - Soft, flexible devices with tissue-like characteristics that can be used for health and wellness, cardiology, and neurology to make surgical diagnosis and treatment easier - based on a new generation of thin, conformal electronics technology that endures bending, twisting, and stretching without sacrificing performance
• Company 147 - Technology that manages the exit sites of central venous catheters by promoting the formation of a biological seal around the catheter that blocks the route for bacteria
• Company 148 - A non-invasive, optical brain monitor for monitoring hypnosis (depth of anesthesia) and level of sedation via direct non-invasive measurement of changes in deoxyhemoglobin (deoxy Hb)
• Company 149 - A disposable skin patch that provides diabetics with a painless, BLOODLESS, easy-to-use, and rapid method for monitoring glucose levels
• Company 150 - Interwoven biopolymer 3D-oriented matrices that more accurately mimic natural extra cellular matrix (ECM) for use in cell and tissue engineering applications
• Company 151 - Revolutionary HyperQ technology based on advanced signal processing of the high frequency ECG signal, enabling more accurate results in the initial diagnosis of coronary artery disease (CAD)
• Company 152 - Optical Ultrasound Tomography(R) (OUT) identifies brain injuries, brain hematomas, malignant breast cancers, and Inflammatory Breast Cancer safely and quickly and displays 3D images in "real time" and can transmit the images to waiting hospitals and surgeons. The cameras are lightweight and portable, and can be mounted on a bedside providing continuous monitoring of hemorrhages and the flow of blood. They can be used in an ambulance, on the battlefield, on the Little League field, and in the ER.
• Company 153 - A scalable molecular diagnostic chip platform that will allow for the diagnosis of diseases in five minutes as well as in-home monitoring of conditions such as: profound venous thrombosis, embolisms, and myocardial infarctions (MI)
• Company 154 - Transcutaneous vagus nerve stimulation to treat patients suffering from drug-resistant epilepsy or other difficult-to-treat neurological and psychiatric disorders
• Company 155 - Implantable device consisting of a series of miniature magnetic beads, linked together to form a "bracelet" around the Lower Esophageal Sphincter (LES) for the treatment of gastroesophageal reflux disease (GERD)
• Company 156 - Wireless 3G cellular-enabled blood glucose meter that instantly transmits glucose values to a care-management server and provides instant feedback and coaching to patients with diabetes
• Company 157 - Accurate, ultra-low-cost whole genome sequencing by way of a simple, single-molecule detection process
• Company 158 - Drug therapy focusing on the carotid body for the treatment of sleep-related breathing disorders
• Company 159 - A unique, high-resolution, and MRI-compatible deep brain stimulation (DBS) system comprising implants with navigation and steering software to treat Parkinson's disease (PD)
• Company 160 - Versatile, easy-to-use, accurate, and cost effective aorto-ostial stent positioning system to facilitate precise stent implantation in coronary and renal arteries
• Company 161 - Device that increases the size of skin grafts without the use of chemicals, biologics, or enzymes
• Company 162 - Immediate and permanent contraception implant for women to use as an alternative to surgical tubal ligation
• Company 163 - Tissue expander technology that allows both diagnostic and therapeutic capabilities never before available during tissue expansion
• Company 164 - Tendon repair device that utilizes a simple and familiar technique to ingeniously join tissue together, with broad applications across a range of surgical sub-specialties
• Company 165 - Novel solutions for wound closure
• Company 166 - Sternal closure system that maintains rigid fixation of the sternum in multiple directions of force and eliminates the common causes of sternal dehiscence
• Company 167 - Bioseparation technology, for use outside of the research lab, with broad applications from molecular diagnostics to transplant therapies
• Company 168 - Non-invasive system for the treatment of acute ischemic stroke and other vascular disorders using externally applied ultrasound that can be rapidly and easily deployed by virtually any emergency room staff
• Company 169 - Genomics-based diagnostic tests for obstructive coronary artery disease (CAD), cardiac arrhythmias, and heart failure (HF)
• Company 170 - Nicotinic receptor agonist compounds for the treatment of asthma and other inflammatory respiratory and non-respiratory diseases
• Company 171 - Femoral vascular access catheter that uses a longer and shallower angle arteriotomy, providing better site closure WITHOUT vascular closure implants
• Company 172 - Surgical instruments, medical lasers, and other medical devices
• Company 173 - KeyHole Cup(R) is designed to provide a safer and efficient entry into the abdominal cavity during laparoscopic surgery. It allows for a more rapid insufflation than standard techniques, mitigating associated risks.
• Company 174 - Cost-effective lab-on-a-chip system that anyone can use to get laboratory quality results in any location, within minutes, and with minimal training
• Company 175 - ImagistxProstate(R), a breakthrough prostate imaging technology providing a diagnostic tool to identify prostate cancer via its 21 MhZ center frequency, 512 element array, and 3D ultrasound capabilities
• Company 176 - Proven patented technology platform that rapidly and accurately measures oxidative stress and oxidizability in blood and other biologic fluids, with multiple diagnostic applications
• Company 177 - Real-time pathology solution for cancer surgical guide, with microchip-based in vivo imaging systems
• Company 178 - A disposable, flexible conduit that provides a protective channel through which an endoscope is inserted for sinus surgery, to keep the introduction site open throughout the course of the procedure, thereby minimizing trauma along the nasal passageway
• Company 179 - The next-generation brain monitor for safer anesthesia and sedation and improved patient outcomes in Operating Rooms (ORs) and Intensive Care Units (ICUs)
• Company 180 - Intelligent continuous glucose monitoring device utilizing recent innovations in microneedle and bluetooth technology, to provide a more accurate and pain-free method than what current devices offer
• Company 181 - Professional and home use devices for automated bladder assessment incorporating a novel, extremely compact, 3D ultrasound scan head and embedded image processing technology
• Company 182 - Ultrasound-based molecular imaging agents that can be used to: 1-diagnose and stage disease, 2-monitor response to therapy in the pharmaceutical research setting, and 3-elucidate the biology of disease processes in the basic science setting
• Company 183 - System for the diagnosis and location of stroke, vasospasm, AVMs, aneurysms, and other brain disorders within minutes, including differentiation of ischemic and hemorrhagic stroke
• Company 184 - Minimally invasive system for decompressing pinched nerves in the spine, based on highly maneuverable tools and a precise tissue-removal mechanism
• Company 185 - The Vortex ZDS(TM) catheter reduces Catheter Associated Urinary Tract Infections (CAUTIs) by at least 50% to replace Foley catheter as the indwelling urinary catheter of choice
• Company 186 - Non-invasive real-time diagnostic tools for early detection, prevention, and management of Acute Kidney Injury (AKI) in critical care environments
• Company 187 - A unique permanent injectable bulking agent for the endoscopic treatment of GERD (chronic heartburn)
• Company 188 - Therapies for the treatment of acute wounds, chronic wounds, scarring, abnormal scarring, inflammation and pain, fibrosis, surgical adhesions, and orthopedic procedures
• Company 189 - A Percutaneous Tracheostomy (PT) system that simplifies the traditional PT technique to be used by more physicians OUTSIDE of the Operating Room (OR) and in faster times than current devices
• Company 190 - Mammary Aspirate Specimen Cytology Test (MASCT System(TM)) that collects a small amount of nipple aspirate fluid (NAF) in 10 minutes, using no radiation and is painless
• Company 191 - Cardiac mapping catheters to analyze electrical heart activity for the diagnosis of cardiac arrhythmias
• Company 192 - Thermal infusion fluid warmer device that enables surgeons to manage and warm up to five fluids at once
• Company 193 - Next-generation insulin analogs for both the rapid-acting and long-acting insulin markets
• Company 194 - New embolotherapy catheter that minimizes reflux when administering medication
• Company 195 - Non-surgical, removable hearing device that transmits sound through the teeth for the treatment of single-sided deafness
• Company 196 - Medical devices for the treatment of neurovascular conditions
• Company 197 - Next generation X-ray scintillator device that provides high resolution imaging
• Company 198 - Permeable, micro-porous, flexible, and user-friendly implants in tubular or patch shape for bone reconstruction and fracture repair in surgical procedures
• Company 199 - Flexible endoscopy and endoluminal surgery device
• Company 200 - Drug therapy for the treatment of inner and middle ear disorders
• Company 201 - In vivo optical imaging devices for real-time diagnosis in a broad range of applications
• Company 202 - Headset that detects and records brainwaves for the diagnosis of Alzheimer's disease and other neurological disorders
• Company 203 - Drug therapy by way of modulating the N-methyl-D-aspartic acid receptor for the treatment of depression and other central nervous system disorders
• Company 204 - Smart-phone based ultrasound imaging system
• Company 205 - Minimally invasive devices using radiofrequency (RF) energy for the treatment of gastroesophageal reflux disease (GERD) and fecal incontinence (FI)
• Company 206 - Portable, non-invasive device designed to offer transcutaneous pulsed electro-magnetic field stimulation therapy for treating post-operative pain and inflammation in superficial soft tissue
• Company 207 - Implantable electronic gastric stimulation device for the treatment of obesity
• Company 208 - High-intensity ultrasound energy for non-invasive reduction of arterial plaque
• Company 209 - Catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels
• Company 210 - Non-invasive tumor ablation and incisionless surgery using high-intensity ultrasound
• Company 211 - Robotic and manual endoscopy devices for increased ergonomics during laparoscopic surgery
• Company 212 - Eye-tracking device for earlier diagnosis of Parkinson's disease and other neurological diseases
• Company 213 - Device that uses localized vibrations to reduce pain during injections
• Company 214 - The first non-invasive, prep-free imaging test for colon cancer
• Company 215 - Biologically-active plastic surgical patch for rotator cuff and tendon injuries, designed to promote healing and formation of new bone
• Company 216 - Catheter-based drug delivery system for the treatment of vascular disease and restenosis
• Company 217 - Anti-infectives for the treatment of severe infectious diseases
• Company 218 - Device for the intraocular delivery of photoactive nanoparticles for the treatment of retinitis pigmentosa, macular degeneration, and diabetic retinopathy
• Company 219 - Venous stenting device and ablation technology for the treatment of chronic venous disease
• Company 220 - Devices that facilitate minimally invasive access to a beating human heart and the delivery of therapeutic options intended to treat complex cardiovascular diseases
• Company 221 - Customized Sound Therapy (CST) system for tinnitus therapy
• Company 222 - Artificial sphincter device for use in ostomy and stoma care
• Company 223 - Microcatheters for treating and preventing acute ischemic stroke
• Company 224 - Spinal probe that uses radiofrequency (RF) ablation on nerves thought to be the cause of chronic back pain
• Company 225 - Disposable device for the prevention of catheter-related infections from hemodialysis
• Company 226 - Single-use needle-free injection system for liquid medications
• Company 227 - Non-invasive Auto-Targeting Neurostimulation (ATN) device for high-stimulation pinpoint treatment of lower back pain
• Company 228 - Portable, patch-based device that delivers "slow release" ultrasound to treat localized pain and induce soft tissue healing
• Company 229 - Shape memory implants that restore motion and eliminate pain for patients requiring soft tissue repair, fracture fixation, or joint fusion
• Company 230 - Removable adhesion barriers for spinal, tendon, and nerve-related surgery to reduce post-operative scarring, pain, numbness, muscles weakness or limited motion
• Company 231 - Orthopedic implants for limb lengthening/correction/reconstruction
• Company 232 - Neurocatheter for the removal of blood clots in the brain
• Company 233 - Portable/mobile nuclear cardiology imaging system
• Company 234 - The first and only wire-independent embolic protection that uses any single guide wire of choice for the entire procedure and seamlessly integrates with standard workflow
• Company 235 - Single-use devices that will address epicardial access, protection, and treatment facilitating the electrophysiologist's ability to perform cardiac ablations more efficiently and with a higher degree of safety and effectiveness
• Company 236 - Irrigation devices for improved visualization during upper and lower gastrointestinal (GI) procedures
• Company 237 - DNA-testing platform that enables results from a wide variety of gene signatures to be delivered quickly, simply, and cost-effectively at the point-of-care (POC) within an hour
• Company 238 - A market leading non-invasive hypoglycemic symptom detection device that protects diabetics from emergency low-blood sugar events. Hypoglycemia healthcare costs average $7,000 per episode and can result in death to the patient.
• Company 239 - High-stability, short-length expandable implants that eliminate the need for complex bone augmentation - shortening overall time to implantation and significantly lowering treatment costs
• Company 240 - System that cools cerebral spinal fluid to reduce injuries associated with spinal and cerebral ischemia
• Company 241 - Infection control technology that does something no other product can - protect and disinfect BOTH the needleless injection site and the end of the IV tubing male luer
• Company 242 - Biodegradable, inflatable balloon device which separates healthy organs from adjacent tumors receiving radiation therapy
• Company 243 - The first passive fetal movement monitor (detector, analyzer, and data logger) for expectant mothers to use at home
• Company 244 - A minimally invasive implantable pulse generator (IPG) to treat obese and type II diabetics by applying electrical stimulation to the duodenum
• Company 245 - Implantable artificial pancreas for the treatment of patients with Type I & Type II diabetes
• Company 246 - Non-invasive hand-held device that detects abnormal heart sounds and uses a smart-phone interface for the diagnosis of coronary artery disease (CAD)
• Company 247 - Aerosol technology which efficiently delivers therapeutics into the abdominal cavity of patients during surgery to combat post-surgical complications such as pain and adhesions
• Company 248 - A self-contained, leadless electrode and an independent miniature pacemaker for the left side of the heart, based on a novel micro-generator that harvests energy from the movement of the heart
• Company 249 - A safe, simple, and cost-effective solution that will revolutionize the vascular anastomosis procedure
• Company 250 - Incubator with 12 fully owned portfolio companies and 20+ fully owned pipeline technologies, driven by unmet market need
• Company 251 - The only device enabling simultaneous, non-invasive, and continuous measurement of blood flow and oxygen saturation
• Company 252 - Functional optical imaging technology for the early diagnosis and guided treatment of blinding retinal diseases and diseases of other organs of the body; it is the only optical imaging approach that allows visualization of the capillaries, non-invasively (without any contrast agent)
• Company 253 - A point-of-care diagnostic system for rapid, sensitive, quantitative biomarker panels that delivers laboratory-quality results in a clinic or doctor's office, within minutes
• Company 254 - Next-generation, cost-effective ophthalmic implants made from STAR(R) biomaterial that will help patients suffering from glaucoma and corneal blindness
• Company 255 - Continuous glucose monitoring system using an intravascular, optical fluorescence-based sensor to support clinical implementation of tight glycemic control (TGC) in the intensive care unit (ICU)
• Company 256 - Non-invasive devices for continuous real-time evaluation of hemodynamic changes
• Company 257 - Grafts for small diameter (less than 5mm) artificial blood vessels in both peripheral and coronary applications
• Company 258 - 1-Deep brain stimulator (DBS) to treat movement disorders, 2-A hybrid auditory implant (HAI) to treat severe hearing loss
• Company 259 - Innovative hydrogel technology for tissue repair including cartilage, bone, and dermal of the knee, wrist, elbow, shoulder, and ankle
• Company 260 - An ophthalmic device company delivering Navigated Retinal Laser Therapy to address the unmet need for durable and cost-effective outcomes in the treatment of major vision-threatening retina diseases, primarily caused by a complication of diabetes
• Company 261 - Best-in-class platform to optimize genes and proteins in human therapeutics
• Company 262 - Cloud/web-based medical imaging data management software and infrastructure as services - to replace picture archiving communication system (PACS) at a significantly reduced cost
• Company 263 - Incubator with over 100 highly novel medical technology inventions spanning most medical markets
• Company 264 - The only minimally invasive cure for spinal stenosis that maintains the natural dynamics of the spine
• Company 265 - Technology to embed Nitric Oxide (NO), part of the innate immune system, into polymer medical devices to make them antimicrobial without the issues of antibiotic resistance
• Company 266 - Minimally invasive catheter-based system that safely, rapidly, and effectively removes thrombus and restores blood flow in the peripheral vasculature utilizing ultrasound energy to destroy clots, without harming adjacent healthy tissue or generating dangerous emboli
• Company 267 - 1-Effective cryosurgical tool that is simple and safe to use without cryogenic gasses or liquids for all medical office skin lesion removal needs, 2-Cervical freeze attachment for gynecology use, 3-Third-generation technology to accommodate cryosurgical treatments for prostate, liver & renal cancers and cardiac aberrant foci ablation
• Company 268 - Remote (wireless) continuous EEG (cEEG) brain monitoring of critical care patients that significantly reduces mortality rates, improves patient outcomes, and saves millions of dollars in patient care expense
• Company 269 - Atherosclerotic plaque dissolution through chemical means for treating occlusive and non-occlusive atherosclerotic disease that may reduce the need for permanent implants like drug-eluting stents (DES), while also potentially addressing plaque instability
• Company 270 - Revolutionary raman-spectroscopy based platform technology licensed from the BC Cancer Agency to aid in the early detection of cancer
• Company 271 - 1-Non-invasive in vitro diagnostic (IVD) blood test for the detection and/or monitoring of 14 different types of cancer, 2-Combination Immunogene Therapy (CIT) technology that could lead to a vaccine or possibly treat those already diagnosed with cancer
• Company 272 - A low-cost, clip-on eye-piece for mobile phones that mimics and replaces the expensive laser-based Shack-Hartmann wavefront aberrometers to diagnose the most common refractive eye disorders: myopia (nearsightedness), hypermetropia (farsightedness), astigmatism, and presbyopia (age-related visual impairment)
• Company 273 - Non-invasive, rapid assessment of dP/dt in Cardiac Resynchronization Therapy (CRT) for lead placement, lead optimization, and monitoring
• Company 274 - Unique, patented, activated collagen, CellerateRX(R) for the expanding diabetes and greater wound care markets
• Company 275 - A medical implant surface technology company focused on the design and manufacturing of proprietary and cellular-friendly interbody fusion devices for the spine
• Company 276 - Anatomically appropriate orthopedic implants, unique instrumentation, and biologics for pediatric and small stature patients
• Company 277 - Proprietary medical devices and patient interfaces for the enhancement of patient safety through capnography monitoring
• Company 278 - 1-Adult stem cell collection and storage, 2-VSEL(TM) (very small embryonic-like) stem cells for tissue regeneration, 3-Contract cell manufacturing for clients around the world, Progenitor Cell Therapy, 4-Therapeutics such as a T-cell regulatory technology to treat disorders of the immune system, 5-A wound healing technology that uses autologous bone marrow-derived stem cells, 6-An autologous bone marrow-derived cell line selected to treat damaged heart muscle following AMI
• Company 279 - A business and technology research & development platform, dedicated to delivering innovative solutions for the musculoskeletal disorders industry
• Company 280 - Ellanse, the first dermal filler family offering a complete customized solution in medical aesthetics
• Company 281 - A Peripheral Nerve Stimulation (PNS) system for patients suffering from severe, intractable pain
• Company 282 - Portable, disposable, non-powered suction device for negative pressure wound therapy (NPWT)
• Company 283 - Device that prepares 10 million micro-droplets per hour for use in drug discovery, genomics, molecular epidemiology, and proteomics
• Company 284 - Non-invasive imaging system for the early detection of pre-cancerous tissue and to guide early treatment intervention
• Company 285 - A handheld breath analyzer for the measurement of fat metabolism
• Company 286 - Portable pediatric vision-screening device for early diagnosis of serious vision abnormalities
• Company 287 - Minimially invasive percutaneous implantable cardioverter defibrillator (PICD) for the treatment of cardiac arrhythmias
• Company 288 - A non-invasive, automatic analyzer that uses measurements of sweat gland activity to determine whether a patient is at risk for diabetes
• Company 289 - Compact, home-based device for male fertility assessment
• Company 290 - Device for the early detection, assessment, and monitoring of mild perceptual impairment (MPI), an early indicator of mild cognitive impairment
• Company 291 - Device providing sustained intravesical drug delivery for the treatment of Overactive Bladder (OAB), Interstitial Cystitis (IC), and other bladder conditions
• Company 292 - Percutaneously-inserted interspinous process fusion cages that provide for stabilization of the spine
• Company 293 - Implantable neurostimulation system for the treatment of obstructive sleep apnea (OSA)
• Company 294 - Physical and chemical resurfacing of orthopedic implants and stents which allows for drug elution without the use of a binding polymer
• Company 295 - Wireless, implantable heart device that allows Congestive Heart Failure (CHF) patients to monitor data using a handheld instrument
• Company 296 - Percutaneous vertebral augmentation (PVA) system for controlling bone cement delivery and leakage during spinal surgery
• Company 297 - Remotely controlled percutaneous catheter system for use in a wide range of interventional applications
• Company 298 - Novel and clinically-validated percutaneous approach for the treatment of functional mitral regurgitation in the heart failure population
• Company 299 - Sutureless, anastomotic connectors to provide a controlled method of joining vessels
• Company 300 - Minimally invasive orthopedic device for the treatment of hip pain
• Company 301 - Handheld device for monitoring chronic disease home-care patients using a single drop of blood
• Company 302 - 1-Novel 510(k)-cleared XCOIL(TM) mechanical thrombectomy device initially targeting DVT and stroke patients and 2-Novel 510(k)-cleared EViTAR(TM) double-lumen, coaxial neurocatheters for intracranial delivery of small molecules, biologics, stem cells/gene-based therapies, and smart sensor enhancements
• Company 303 - Microwave-based soft tissue ablation
• Company 304 - Implantable device to treat epilepsy by anticipating seizures and delivering intracranial drugs
• Company 305 - Injectable, synthetic bone subsitutes
• Company 306 - Device that delivers iron transdermally for patients with iron-deficiency anemia
• Company 307 - Implantable pacing and defibrillation device that detects the early onset of atrial fibrillation and chronic heart failure and delivers targeted medications
• Company 308 - Device for dry powder pulmonary delivery to treat patients with Parkinson's disease
• Company 309 - A thrombectomy catheter for peripheral artery disease (PAD) that features a rotating, extending tip
• Company 310 - A unique, non-invasive tool for the analysis of muscle function to assist in the evaluation and treatment of neck and back injuries and illnesses
• Company 311 - Vital signs monitoring device for use as an early congestive heart failure (CHF) crisis indicator at home, to avoid acute/expensive hospitalizations
• Company 312 - Novel bioresorbable regenerative scaffolds that provide 3D architecture for enhanced tissue repair
• Company 313 - Novel implantable ultrasound flow-measuring devices with flow data wirelessly transmitted from within the body
• Company 314 - Technology for nurses/pharmacy technicians/emergency responders to more safely and effectively vaccinate the public in the event of a biological or viral pandemic
• Company 315 - Modular, powered, proprietary articulating technology for endoscopes and laparoscopes, enabling surgical safety, flexibility, and procedural innovations
• Company 316 - Medical image viewing solution that enables physicians to access/view critical patient images/information from anywhere, without compromising the security/privacy of the data
• Company 317 - An elegant, user-friendly alternative to traditional eye dropper bottles that will allow multi-dose of preservative-free ophthalmic formulations
• Company 318 - Device-based technology with an anti-inflammatory therapeutic platform to appreciably widen the present window of treatment for ischemic stroke to 12-18 hours
• Company 319 - A unique Sharklet-patterned urinary catheter that will reduce catheter-associated urinary tract infections (CAUTIs)
• Company 320 - StimBrace addresses osteoarthritic knee pain by intelligently strengthening leg muscles to stabilize and brace the knee during real-world use
• Company 321 - Image-guided interventional endoscopy products
• Company 322 - An expandable, funnel-shaped cannula for the removal of intravascular material during extracorporeal circulation
• Company 323 - Teraherz-based, real-time, video-rate imaging system
• Company 324 - A wearable product that uses Touch Activated Phlebotomy (TAP) technology to reduce the inconvenience of blood sampling and facilitate simpler diagnoses
• Company 325 - Radiofrequency (RF)-based detection systems to reduce the risk of retained surgical sponges
• Company 326 - A removable surgical implant to improve vision loss resulting from presbyopia
• Company 327 - A minimally invasive, green, laser-based technology for the treatment of benign prostatic hyperplasia (BPH), as an alternative to traditional TURP surgery
• Company 328 - An artificial silicone microchip, which stimulates retinal cones and rods to restore retinal function
• Company 329 - An automated, continuous glucose monitor for bedside use in intensive and critical care
• Company 330 - A small, injectable ophthalmic implant containing multiple, laser-activated reservoirs designed for the on-demand, physician-controlled release of ocular drug therapies to the back of the eye
• Company 331 - A non-invasive, portable device that treats glioblastomas with electrical fields
• Company 332 - An implantable, bionic retina for patients with degenerative retinal diseases
• Company 333 - 1-Biochemical sensing technologies for continuous glucose monitoring and 2-Drug-delivery devices for osteoporosis management
• Company 334 - Less invasive technologies and a more effective option for Primary Open Angle Glaucoma patients
• Company 335 - 1-A long-term cardiac rhythm monitor and 2-A disposable electrocardiography (ECG) monitor for use for up to 30 days
• Company 336 - Devices for arthroscopy, hip, knee, and spine surgery, in addition to radiofrequency identification (RFID) tracking technology
• Company 337 - A percutaneous implant for mitral valve repair
• Company 338 - Capsule-based hydrogels to reduce food intake in obese patients
• Company 339 - Novel, implantable cardiovascular device
• Company 340 - Whole-body imaging technology for orthopedic applications
• Company 341 - Advanced surgical devices for ear, nose, and throat (ENT) surgery
• Company 342 - 3D full-breast ultrasound imaging device for the detection of benign or malignant masses
• Company 343 - Radiofrequency (RF)-based device for the treatment of congestive heart failure (CHF)
• Company 344 - A wireless, touch-screen insulin pump featuring a blood glucose meter, food library, and an activity monitor
• Company 345 - Synthetic cartilage technology for joint repair
• Company 346 - A vertebral restoration system that uses spine-specific osteogenic biomaterials to restore vertebral stability
• Company 347 - Advanced long-term hemodialysis and peritoneal dialysis catheters
• Company 348 - Portable and advanced point-of-care diagnostics equipment
• Company 349 - Endovascular device targeting the treatment of abdominal aortic aneurysms (AAAs)
• Company 350 - A wireless, remote-controlled unit targeting tissue expansion for breast reconstruction
• Company 351 - User-friendly, simple, and needle-free transdermal delivery system that can deliver a broad range of compounds, including: peptides, proteins, small molecules, and vaccines
• Company 352 - Brachytherapy device for gynecological cancers
• Company 353 - Ophthalmic implant for improved vision in patients with end-stage age-related macular degeneration (AMD)
• Company 354 - Small, disposable, discreet, and very convenient alternative to CPAP for obstructive sleep apnea (OSA) patients
• Company 355 - A wearable, battery-operated, bionic leg - used as a robotic aid during therapy sessions, until the patient recovers their gait so they can walk/continue to improve without it
• Company 356 - Surgical films, meshes, sutures, and other products constructed from a new class of absorbable biomaterials
• Company 357 - Advanced sealants and anti-adhesion agents for use in vascular and general surgery
• Company 358 - Devices to treat diseases and injuries of the foot and ankle, resulting in faster ambulation, superior cosmesis, and less pain
• Company 359 - Benchtop-based positron emission tomography (PET) imaging system
• Company 360 - System that features an intramedullary implant for fusion or fixation of the sacroiliac (SI) joint using a small incision
• Company 361 - Magnetic technology used to destroy blood clots
• Company 362 - P.L.E.A.S.E.(R) (Precise Laser Epidermal System) - a novel transdermal delivery device for high molecular weight drugs, that can be used by medical personnel or the patient
• Company 363 - Technology platform that uses physical vapor deposition, thin film technology, and thin film metals to produce stents and other implants that feature greater biocompatibility
• Company 364 - Laparoscopic devices for single-port surgery and natural orifice transluminal endoscopic surgery (NOTES)
• Company 365 - Device that stimulates the urinary bladder electrically in order to modulate key renal functions, thus, breaking the vicious cycle of cardio-renal interaction in congestive heart failure (CHF) patients
• Company 366 - Endometrial ablation system that uses a low-profile insertion diameter, automatic power settings, an atraumatic tip, and an ergonomic handle, to provide therapy quickly and comprehensively
• Company 367 - A two-step treatment for ischemic stroke patients that provides rapid reperfusion as well clot capture and retrieval
• Company 368 - Transcatheter cardiac valve replacement technology
• Company 369 - Laser system that uses an integrated ocular measurement technology and short-pulse laser to perform surgical incisions for refractive cataract surgery
• Company 370 - Advanced surgical field illumination technologies to improve surgeon visualization and reduce surgeon fatigue in less invasive surgery
• Company 371 - Home dialysis system that integrates multiple, advanced micro-technologies
• Company 372 - Deep brain stimulation (DBS) technology for the treatment of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI)
• Company 373 - External fixation system that uses specialty clamps to: reduce the construct weight, enable greater flexibility for the surgeon, and reduce operating times
• Company 374 - Ablation system that uses a specialty catheter to deliver low-pressure liquid nitrogen for tissue ablation during endoscopy
• Company 375 - Disposable device to provide fast, objective measurement of vaginal cervical length, which assists in the determination of whether the patient is undergoing preterm labor
• Company 376 - Optical sensing technology for non-invasive pH monitoring of stored platelets
• Company 377 - Software allowing physicians to remotely monitor vital signs using smartphones and hybrid tablet devices such as the iPhone, BlackBerry, Android, Windows Mobile devices, and iPad/Android-based tablets
• Company 378 - Patch-based technology that delivers a weekly, low-dose contraceptive to women
• Company 379 - Integrated system that monitors the activity of patients and caregivers in long-term care environments and features a proprietary fiberoptic sensor to detect patient movement, thereby detecting falls and helping to prevent pressure ulcers
• Company 380 - Remotely-operated, in vivo, miniature robotic products for laparoscopic surgery
• Company 381 - Angioplasty stenting system intended to reduce procedure times
• Company 382 - Integrated system comprising reusable and disposable devices, components, and software to enable magnetic resonance imaging (MRI)-guided neurological procedures
• Company 383 - Devices used to assist in the introduction and advancement of endoscopes in the upper and lower gastrointestinal (GI) tract
• Company 384 - Wireless platform for continuous monitoring of vital signs
• Company 385 - 510(k) cleared device using acoustic reflectometry to continuously monitor breathing tubes for placement, movement, and obstruction, enabling adverse event prevention
• Company 386 - Platform of technologies used to lower intraocular pressure (IOP) for glaucoma patients, including the Gold Shunt implant, the 790 laser for trabeculoplasty, and a sensor to continuously monitor IOP
• Company 387 - Paddle that measures the mechanical properties of breast tissue during mammography, reducing pain and discomfort
• Company 388 - Implantable neurostimulation device to treat inflammation
• Company 389 - Repositionable transcatheter aortic valve replacement system
• Company 390 - Technology to treat cardiac arrhythmias
• Company 391 - Diagnostic system for hematology and HIV-immune monitoring in developing countries
• Company 392 - Bronchoscopically-placed nitinol coil for lung volume reduction
• Company 393 - Controlled electrical pulses delivered to nerve clusters to improve swallowing function and control in patients with acute dysphagia
• Company 394 - Hand-held device intended for use in facial rejuvenation
• Company 395 - Hand-held device that deactivates the axillary glands using electromagnetic energy, thereby eliminating the problem of massive underarm sweating
• Company 396 - Hand-held point-of-care and home-based testing devices that measure blood viscosity for patients taking Warfarin
• Company 397 - 3D scanning technology that measures ear canal shape and tissue compliance
• Company 398 - Bioabsorbable drug-eluting stent for chronic sinusitis patients
• Company 399 - Catheter securement system that features a small anchor placed subcutaneously
• Company 400 - Wireless systems to enable remote safety and wellness monitoring for geriatric patients
• Company 401 - An intravascular continuous glucose monitor comprising a single-use catheter and sensor system that enables direct measurement of plasma glucose in flowing blood
• Company 402 - Non-invasive meters for continuous glucose monitoring
• Company 403 - Products to treat orthopedic trauma
• Company 404 - Drug-eluting balloon product for cardiac and peripheral arteries
• Company 405 - Advanced vascular closure device designed to reduce the time to hemostasis
• Company 406 - Low-energy, pain-free atrial cardioverters for atrial fibrillation (AF)
• Company 407 - Combines imaging technology and advanced algorithms to assess early embryo viability at the 4-cell stage
• Company 408 - Radiofrequency-based ablation catheter for atrial fibrillation (AF) that features integrated microwave radiometry technology
• Company 409 - Non-surgical procedure to reverse some of the physical effects of vaginal childbirth
• Company 410 - Intravenous (IV) catheter system which substantially increases successful IV insertions and provides top-of-class passive needle safety; also applicable to many other vascular access applications where higher success rates and less vessel trauma are important
• Company 411 - Spine implant system that stabilizes and restores the spinal anatomy of persons that have suffered a vertebral compression facture (VCF)
• Company 412 - 1-Trans-nasal catheter for real-time imaging of atrial fibrillation (AF) ablation procedures; 2-Intra-cardiac catheter for real-time image guidance of percutaneous valve and other structural heart repair procedures; 3-High-definition intravascular ultrasound (IVUS) system, with near-OCT image resolution; and 4-Image-guided, endoventricular injection catheter for stem cell and/or biological agent therapy for congestive heart failure (CHF)
• Company 413 - Next-generation solution for patent foramen ovale (PFO) closure that directly treats the pocket of the PFO (in-tunnel closure), while minimizing the impact to the atrial spaces
• Company 414 - Hydrogel-based ocular bandage to protect clear corneal incisions following cataract and intraocular lens placement surgery, covering vulnerable tissue as the incision heals, and reducing pain and discomfort in the days following surgery
• Company 415 - Hand-held intra-operative surgical probe used in diagnosing, staging, and treating breast cancer, to reduce residual cancer/repeat surgery after breast cancer lumpectomies
• Company 416 - Effective antimicrobial coatings and compounds that are broad-spectrum and fast-acting against clinically relevant pathogens, including multi-drug resistant strains such as MRSA
• Company 417 - Next-generation drugs with better efficacy and safety, plus longer duration of action, for rheumatoid arthritis, anemia, organ transplants, and blood diseases
• Company 418 - Next-generation extracellular matrix (ECM) products for advanced wound healing and tissue regeneration, with improved handling, strength, resorbability, and infection control over existing products
• Company 419 - Low-cost disposable devices that enable efficient and patient-friendly delivery of colonoscopy and colon prep services at convenient care settings on a walk-in basis
• Company 420 - System that provides a new direction in dialysis, through a new mode of access through two implantable ports that allow safe repeated access into arteries and veins, so that the dialysis process works with the natural direction of blood flow
• Company 421 - Polymer-based liquid bandage with antimicrobial properties to: cover intact skin or minor cuts, scrapes, burns, and minor irritations of the skin; help keep them clean and dry; and help protect them from infection
• Company 422 - Disruptive diagnostic platform, using an innovative multi-modality approach, to advance cardiovascular health assessment for the prevention of heart attack and stroke
• Company 423 - Fixation with compression technology that offers significant improvement over existing products with applications in small & long bone, spine, and the sternum
• Company 424 - First spinal instrumentation system developed specifically to restore healthy kinematics in lumbar flexion for the treatment of lumbar spinal stenosis with or without degenerative spondylolisthesis
• Company 425 - A portable pneumatic compression system for the treatment of venous and arterial insufficiency, to be used in the hospital, secondary care facility, and home
• Company 426 - Revolutionary portable device to provide easy and efficient screening methods for early detection of age-related macular degeneration, diabetic maculopathy, and other types of retinal disease in the human eye
• Company 427 - Highly effective non-toxic cancer therapy based on the use of recombinant human alpha-fetoprotein conjugated with cytotoxic drug
• Company 428 - Orthopedic implants for the reconstruction of distal extremities
• Company 429 - Implant fault detection and monitoring technology
• Company 430 - Leak-proof, rupture-proof breast implant technology, with the potential to replace all existing saline and gel implants
• Company 431 - Next-generation ultrasound technology for non-invasive fat and wrinkle reduction, with multiple clinical applications in one device and no surgery or anesthesia
• Company 432 - Highly multiplexed real-time PCR-based assays for the accurate detection of hospital-acquired antibiotic resistant bacteria such as MRSA, MSSA, and pathogens causing Sepsis and gastrointestinal infections
• Company 433 - 24-hour intraocular pressure monitoring of glaucoma patients by a telemetric, implantable micro sensor
• Company 434 - Electrochemical biosensors for the in-hospital diagnostics, home health care, and consumer diabetes markets
• Company 435 - New medical grade preservative that is non-toxic and capable of preserving urine, blood, plasma, and serum at room temperature; designed and used by the space program
• Company 436 - Molecular diagnostics and therapeutics for back-related and joint-related pain
• Company 437 - Technology that can detect in real time an acute myocardial infarction and derive a 12-22 lead ECG with only 3 leads or 5 electrodes
• Company 438 - Minimally invasive surgical suturing devices, using standard type curved needles and all standard sutures, for conventional and single-port laparoscopy, urogynecology, cardiac surgery, and endoscopic interventional therapies, including NOTES
• Company 439 - IVC filter utilizing unique anchoring technology that allows for optimal placement during implantation, superior migration resistance in vivo, and easy retrieval after the threat of PE has been eliminated
• Company 440 - Effective, reliable use of autologous adult stem cells (ASCs) to enhance fusion in spine and orthopedic surgery
• Company 441 - Fail-safe and inexpensive system that employs a technology to prevent errors in the intravenous administration of drugs and blood transfusion
• Company 442 - Device that applies gentle pulsing forces, in combination with standard orthodontics, to move teeth faster through accelerated bone remodeling
• Company 443 - Forward-looking intravascular ultrasound (FLIVUS) catheters that can determine correct stent size and placement through a field of view which extends beyond the catheter tip
• Company 444 - Lightweight and portable system with unsurpassed fluid balance accuracy for blood purification and fluid management
• Company 445 - Single-use, disposable "sensing embedded" surgical glove 1-to accurately map cervical length/dilatation during pre-term/full-term labor, 2-as a tool in general surgery, and 3-as a tool in telemedicine
• Company 446 - Reagents for use in non-invasive MRI, PET, and optical imaging
• Company 447 - Non-invasive device that acts as a robotic physical therapist for treating chronic head and neck pain
• Company 448 - A genomics diagnostic tool company, with a transformative technology that integrates sample preparation and sequencing on a chip, delivering actionable data in the doctor's office; supported by a $30 million large grant project with access to 15 million samples associated with cradle to grave electronic medical records established a decade ago
• Company 449 - Patient monitoring system providing real-time continuous information via four physiological parameters - sensed at the tissue level, reflecting the patient's systemic metabolic state
• Company 450 - Prevention and treatment of osteoporosis-related fractures
• Company 451 - High-performance, inexpensive, single-use disposable dry-powder inhaler (DPI) suitable for hospital and OTC use, as well as acute applications
• Company 452 - Growth factor, stem cell, scaffold, and bioadhesive technologies that improve the body's ability to regenerate healthy cartilage, improve joint function, and prevent degenerative disease
• Company 453 - Bioceramics for the treatment of post-myocardial infarction (MI), mitral valve regurgitation, applications to coronary and peripheral stents, and other technologies
• Company 454 - Cost-effective, laser-based antimicrobial treatments for Chronic Rhinosinusitis (CRS)
• Company 455 - Modular, 3D, real-time, stereoscopic vision and recording systems to change the surgical paradigm from 2D to 3D-HD stereoscopic vision for minimally invasive surgery (MIS)
• Company 456 - Next-generation infusion pump platform to bring new standards of accuracy and ease-of-use to the hospital and homecare markets
• Company 457 - Non-hormonal, one-size-fits-all intravaginal contraceptive ring
• Company 458 - Single-use high-definition (HD) surgical camera that will provide high-quality HD imaging at a fraction of the price of current market leading HD cameras
• Company 459 - Endoscopic accessory devices that fill unmet needs in the field of gastrointestinal (GI) endoscopy
• Company 460 - Needle technology that reveals visible blood flow at the instant of vein penetration without activation or additional instruction
• Company 461 - Non-invasive method for detecting the presence of a right-to-left cardiac shunt (i.e., PFO) to enable medical treatment and/or closure before the occurrence of a debilitating or life-threatening stroke or heart attack
• Company 462 - Patent-protected, FDA-approved, gentler power-assisted liposuction devices offering more controlled and faster fat removal, with less trauma to the doctor and patient
• Company 463 - Technology for: 1-prophylactic treatment of allergic asthma and 2-infection control in surgical theatres
• Company 464 - Non-invasive, controlled, and sustained release back-of-the-eye therapeutics for sight-threatening diseases such as: severe uveitis, diabetic macular edema, and age-related macular degeneration (AMD)
• Company 465 - Technology that can regenerate nerves
• Company 466 - Compound that can regenerate new blood vessels and has a biodegradable stent
• Company 467 - Tissue-engineered, autologous heart valves for the replacement of malformed or malfunctioning heart valves
• Company 468 - The first robotic system capable of offering full force-reflection to laparoscopic surgeons in any surgical practice
• Company 469 - An intraocular lens, customized to the patient's vision needs and adjustable throughout the patient's life, for greater quality of vision
• Company 470 - Minimally invasive stents to treat patients suffering from dysfunctional uterine bleeding (DUB), urinary tract obstruction, prostate enlargement (BPH), or prostate cancer
• Company 471 - 1-Real-time device navigation and positioning system for cardiovascular interventions and 2-Real-time angiography-based system, designed to assist in delivery of a transcatheter heart valve (THV)
• Company 472 - Biomimetic prosthetic vascular grafts that are transformed in the body into bioartificial arteries which resemble "healthy" arteries in form and function
• Company 473 - Third-generation thrombectomy device for restoring blood flow in patients who have suffered acute ischemic strokes
• Company 474 - Flexible endoscopic tools for interventional gastroenterologists to perform therapeutic procedures
• Company 475 - Modern, sophisticated system to ensure a proper blood match is obtained and the patient gets the correct cord blood unit in a timely manner
• Company 476 - Implantable device to treat patients with left ventricular dilation following a Myocardial Infarction (MI) heart attack
• Company 477 - Blood glucose monitoring system designed to integrate test strips, the lancing device, and lancets into one compact glucose meter
• Company 478 - A wound dressing constructed from a biocompatible matrix and coagulating agents
• Company 479 - A handheld, wireless device that detects potential perforations of the vertebral cortex during pedicle preparation for spine surgery
• Company 480 - Hand-held, battery-powered product using intense therapeutic ultrasound (ITU) technology for skin care
• Company 481 - Bone cement for cranial defect repair
• Company 482 - A vascular robotic system designed to place coronary guidewires, stents, and balloon catheters during percutaneous coronary interventions
• Company 483 - An integrated system featuring sensors and software to enable the monitoring of seniors in multiple care settings
• Company 484 - Minimally invasive therapy for enlarged prostate
• Company 485 - Controlled Deployment Technology (CDT), which uses a low-profile access sheath that may be increased to provide a wider working diameter
• Company 486 - A portable device that provides therapeutic hypothermia in emergency care settings
• Company 487 - Hand-held, disposable nerve stimulator for use during surgeries
• Company 488 - An absorbable skin stapler for skin closure that eliminates the need for removing staples after surgery
• Company 489 - Esophageal cardiac monitoring device for use in surgery and critical care
• Company 490 - Proprietary devices for obtaining, shaping, and implanting ankle and knee cartilage grafts from foot joints
• Company 491 - Quantitative and qualitative cardiac assays to assist in the diagnosis of cardiovascular diseases at the point of care
• Company 492 - Advanced, portable and easy-to-use noninvasive devices for the assessment of traumatic brain injury (TBI) at the point of care
• Company 493 - Next-generation wellness program with sophisticated physical and mental health diagnostic software
• Company 494 - Combination of a proprietary ELISA substrate with Raman spectroscopy to dramatically increase the performance of immunoassays for diagnostics, research, and drug discovery
• Company 495 - Surgical instruments to reduce the trauma of full access surgery
• Company 496 - Non-ablative skin rejuvenation technology which produces immediate and visible aesthetic improvement together with long-term skin remodeling effects
• Company 497 - Implantable medical device that helps diabetic patients control their eating habits, lowering their blood glucose and body weight, by applying electrical stimulation to the stomach during meals
• Company 498 - Ophthalmic devices for minimally invasive treatment of corneal blindness and vision correction using proprietary corneal implants and microsurgical instrumentation
• Company 499 - Device that measures the presence, progression, and severity of any disease condition and the effectiveness of treatment and timing of non-acute death
• Company 500 - Non-obtrusive CPAP mask that uses the natural oral cavity anatomy to create the seal required for effective CPAP treatment
• Company 501 - rEEG(R) technology for the assessment of neurophysiological abnormalities and determination of psychiatric treatment
• Company 502 - Miniaturized wireless telemetry, physiological monitoring, and rehabilitation devices including applications in electrophysiology, sleep disorders, and movement disorders
• Company 503 - Dedicated Diabetic Machine (DDM) insulin regulation therapy for type 2 diabetes
• Company 504 - Non-invasive glucose monitoring device targeting the eye
• Company 505 - Universal oncology, cardiology, stroke and diabetes molecular imaging agents
• Company 506 - Implantable hearing device that provides extraordinary acoustic performance in a completely invisible device
• Company 507 - Surgical sponge detection using radiofrequency identification
• Company 508 - Home monitoring technologies with automatic fall detection capabilities
• Company 509 - Implantable neuromodulation devices for epilepsy and other neurological disorders
• Company 510 - Unique non-invasive blood pressure and cardiac output monitor, offering a precise hemodynamic profile with real-time data posted within a minute
• Company 511 - Single-port, multi-channel laparoscopic surgical platform
• Company 512 - Advanced over-the-wire vascular access device
• Company 513 - Technologies that improve visualization during laparoscopic surgery, permit laparoscopic suturing, and enable simpler removal of ureteral stones
• Company 514 - Portable hyperthermic perfusion system for raising the core temperature of the thoracic or peritoneal cavity
• Company 515 - Optical guidance systems for computed tomography (CT), fluoroscopy, and magnetic resonance imaging (MRI) procedures
• Company 516 - Liposome-encased nanoparticles for computed tomography (CT) contrast imaging
• Company 517 - Cartridge-based portable hemodialysis machine
• Company 518 - Capillary force vaporizer technology
• Company 519 - Home-based diagnosis of sleep disorders
• Company 520 - Office-based, minimally-invasive ablation device for enlarged prostate
• Company 521 - Medical imaging technologies for clinical and pre-clinical applications
• Company 522 - Ultrasound systems powered by the Scan Engine, a device that may be interchanged with any of the company's 3 carts, promoting efficiency and cost-effectiveness
• Company 523 - A drug-eluting stent coated with bioabsorbable polymers
• Company 524 - Parts and services for new and refurbished imaging and patient monitoring technologies
• Company 525 - Inhalation delivery technologies
• Company 526 - Synthetic bone substitutes
• Company 527 - Organ-specific molecular imaging
• Company 528 - Image analysis for the diagnosis of Alzheimer's and other diseases
• Company 529 - High-speed, disposable dental drill
• Company 530 - Software systems for cardiology
• Company 531 - Spinal implant for remote-controlled spine deformity and trauma correction
• Company 532 - Endoluminal treatment for morbid obesity
• Company 533 - A non-invasive diagnostic medical device that replaces the current traumatic procedure used to detect pediatric VUR (urinary reflux) and prevent kidney damage in 4M children annually
• Company 534 - Highly differentiated aorto-ostial stent and delivery platform for both peripheral and coronary applications
• Company 535 - Medical records application on a simple USB flash drive for patients, providers, and insurers
• Company 536 - Intelligent orthopedic devices that will address the growing clinical and economic cost of orthopedic implant failure and osteoporosis
• Company 537 - Pro-Vas is a novel less-invasive alternative to vasectomy for men seeking permanent contraception
• Company 538 - Minimally invasive lumbar annular repair technologies to prevent disc re-herniation and interrupt disc degeneration
• Company 539 - Web-based service platform, enabled by an imaging technology, for the remote evaluation of skin cancer
• Company 540 - Device to non-invasively detect and monitor blood borne diseases in vivo, without taking blood
• Company 541 - Products ranging from needleless injection site connectors, to safety syringes, and biodiagnostic sampling devices
• Company 542 - Products for the urinary incontinence market
• Company 543 - New medical diagnostic system for the early detection of lung cancer
• Company 544 - Non-invasive ultrasound device for the treatment of glaucoma
• Company 545 - Technology that will impact the way surgeons perform laparoscopic surgery, making it possible for one surgeon to do what now requires two, and to reduce the number of surgical incisions for most all procedures
• Company 546 - Varicose vein stripping under direct vision for ablation of the diseased saphenous vein in a kit that reduces trauma, minimizes bleeding, and expects improved clinical outcomes
• Company 547 - Advanced biofeedback stimulator with diagnose and treatment modes
• Company 548 - Device for treating diseases in patients with acute renal failure (ARF) and acute inflammation induced by cardio pulmonary bypass (CPB) surgery, to produce improvement in survival rates and reduce costs
• Company 549 - Technology that bridges the gap between low-tech aspiration and complex electromechanical aspiration systems for use in thrombus removal, rotational vacuum assisted biopsy, tissue resection, and spinal disc decompression
• Company 550 - A handheld device for the as-needed treatment of allergic rhinitis
• Company 551 - Non-compressible hemostatic fibrin sealant for high-volume bleeding in intraoperative surgery and trauma
• Company 552 - Minimally invasive device for midface lift and other lift procedures
• Company 553 - Robotic ankle and foot prosthesis
• Company 554 - Handheld CD4 cell counter
• Company 555 - Auto-adjusting portable oxygen system
• Company 556 - Magnetically-guided enteral feeding tube
• Company 557 - Wireless electrocardiography
• Company 558 - Human fibrinogen-based tissue sealant
• Company 559 - Gastrointestinal endoscopy products
• Company 560 - Interventional cardiology devices for chronic total occlusions
• Company 561 - Dental imaging
• Company 562 - Type 1 Diabetes medication delivery
• Company 563 - Transdermal therapeutics for neurological and psychiatric diseases
• Company 564 - In-situ formed hydrogels for radiation oncology and oncologic surgery
• Company 565 - Protein signature-based diagnostic tests for prostate, lung, and breast cancers
• Company 566 - Synthetic polymer for osteoarthritis therapy
• Company 567 - Controlled warm air delivery device for human head lice removal
• Company 568 - Polymolecular system for the treatment of inflammatory disease
• Company 569 - Critical care monitoring technologies
• Company 570 - Advanced feeding tube technology which can be placed using ultrathin endoscopes
• Company 571 - An accurate, low-cost home healthcare device for use by patients to self-measure Intraocular Pressure (IOP)
• Company 572 - Ultrasonic technologies and related techniques for aesthetic surgery
• Company 573 - Therapeutic ultrasound to treat hypertension
• Company 574 - Breast imaging system for early breast cancer detection
• Company 575 - RFID technology and software systems for medical device manufacturers, distributors, and hospitals
• Company 576 - Smart card platform that identifies and authenticates a patient to the healthcare provider and matches the patient to his or her medical record
• Company 577 - "Lap-Pak" is a flexible, one-piece, device contoured to enable the rapid and secure re-positioning of the bowels to expose the surgical site while eliminating the need for re-positioning during surgery
• Company 578 - Enhanced meter dose inhalers and spacer devices for the treatment of Asthma and COPD
• Company 579 - Sensor-based, video-monitored, automatic/semi-automatic laryngoscope that makes intubation easy, safe, and fast
• Company 580 - The first point-of-care device able to give a rapid determination of platelet quality through a multi-dimensional test, thus, avoiding the use of poor quality platelets and improving transfusion outcome
• Company 581 - Portable diagnostic device used to determine the presence and level of Myocardial Ischemia (MI)
• Company 582 - Suite of diagnostic imaging products using near-field and forced-resonance principles targeting several specialties including cardiology, oncology, orthopedics, and neurology
• Company 583 - Rapid endovascular vessel occlusion and blood flow interruption
• Company 584 - Flat panel x-ray sources for use in sterilization systems, compact CT systems, and a non-radioactive blood irradiator
• Company 585 - Non-invasive, easy-to-use device that uses pulsed radio frequency energy (PRFE) for tissue growth, wound healing, and pain relief
• Company 586 - Robotic assistance device for CT-guided soft tissue interventions
• Company 587 - Fatigue-resistant/fiber-reinforced bone cement for orthopedic joint replacement
• Company 588 - Full line of products specifically dedicated to avoiding a total joint replacement and preserving the shoulder, hip, knee, or ankle joints
• Company 589 - Single-use, disposable silver ion delivery device to treat Osteomyelitis (OM)
• Company 590 - Micro-format, CMOS-based, imaging technology for minimally-invasive, disposable endoscopic medical procedures
• Company 591 - Fish-skin-derived tissue regeneration technology for chronic wounds and hernia repair that improves upon current human and porcine technologies through improved economics & clinical performance, reduced disease transfer risk, and absence of cultural constraints on usage
• Company 592 - Hand-held ultrasound tool that displays a see-through image in the medical practitioner's line of sight, at the patient's skin surface
• Company 593 - Minimally invasive ultrasound-guided RF ablation system to treat symptomatic uterine fibroids through a transcervical approach
• Company 594 - Products for minimally invasive bypass surgery
• Company 595 - Rapid/sensitive/cost-effective diagnostic products for detecting microbes causing hospital associated infections
• Company 596 - Diagnostic products for rapid infection determination at the point-of-care (POC) for professional and consumer markets
• Company 597 - Cancer immunotherapy device, which selectively removes specific blood-borne inhibitors of the immune system
• Company 598 - POC/PST device to directly detect clot formation and do it in real time
• Company 599 - 1-Low-cost, disposable point-of-care (POC) Pap smear replacement requiring no lab or technician; 2-Disposable, woman-controlled, cervical cap embedded with an anti-HIV drug to provide contraception and help prevent infection from HIV
• Company 600 - Small/wearable/all-mechanical insulin delivery device containing a 3-day supply of insulin
• Company 601 - The next major step in the treatment of early breast cancer: replacing lumpectomy with a percutaneous, minimally invasive outpatient procedure under local anesthesia that not only eradicates the cancer, but is not disfiguring and leaves no scar
• Company 602 - Stand-alone/rapid/autologous cell harvesting processing and delivery technology
• Company 603 - System that measures airway inflammation to determine asthma severity for improved treatment
• Company 604 - Minimally invasive, image-guided therapies to treat back pain
• Company 605 - Products enhancing focally-delivered radiation and drug therapies for patients with spinal metastatic disease or bone tumors
• Company 606 - Needle-free drug delivery for migraine attacks and cluster headache episodes
• Company 607 - Image-guided ultrasound for prostate cancer tissue ablation
• Company 608 - Obstetric position tracker and ultrasound technology
• Company 609 - Compact ultrasound devices
• Company 610 - Continuous blood glucose measurement devices
• Company 611 - Radiosurgical therapy for neurovascular and inflammatory ocular conditions
• Company 612 - Wound closure technology
• Company 613 - Neurosurgical tumor removal
• Company 614 - Surgical device for treating benign prostatic hyperplasia (BPH) and other conditions
• Company 615 - Radiofrequency balloon catheter technology
• Company 616 - The TOPS(TM) System is an implantable device that allows axial rotation, lateral bending, extension, and flexion. The implant facilitates bending, straightening and twisting movements at the affected segment of the spine while blocking excessive posterior and anterior sagittal translation.
• Company 617 - Implants for sensorineural hearing loss
• Company 618 - Medical textiles for hemostasis
• Company 619 - 1-System for use in spinal surgical procedures such as vertebroplasty, 2-System to provide immediate vascular access through the intraosseous space for the delivery of essential drugs and fluids, 3-System for aspirations, biopsies, and stem cell collections
• Company 620 - Pressure cycling technology (PCT) to safely, conveniently, and reproducibly control the actions of molecules in biological samples
• Company 621 - Low-cost technology to survey the genome in its native state, in context, and at ultra-high resolution, without the need for DNA amplification
• Company 622 - Temperature management technology to treat hyperthermia and hypothermia, prevent damage from stroke, and enhance cancer therapies
• Company 623 - Optical technology for correcting presbyopia
• Company 624 - Non-invasive radiofrequency (RF) energy-based system to treat vaginal stretching caused by childbirth
• Company 625 - High-quality, cost-efficient, single-room proton beam radiotherapy (PBRT) system as an alternative to conventional high-energy x-rays
• Company 626 - Controlled, targeted deep-tissue therapeutic warming system to promote pain relief, reduce joint stiffness, and enhance recovery/rehabilitation programs
• Company 627 - 1-Artificial larynx, 2-Ear, nose, and throat (ENT) prostheses/implants
• Company 628 - microRNA-based tests to diagnose various cancers and gastrointestinal diseases
• Company 629 - Brain training software aimed at enabling individuals to strengthen cognitive function using the concept of neuroplasticity
• Company 630 - Non-invasive near-infrared (NIR) laser energy for the treatment of: acute ischemic stroke, spinal cord injury, traumatic brain injury, global cerebral ischemia, spinal cord injury, Alzheimer's disease, Parkinson's disease, and sepsis
• Company 631 - Hydrogel materials that can be fabricated into devices, nanogels, and polymer solutions with applications in ophthalmology as well as cardiology, urology, and tissue engineering
• Company 632 - Advanced polymer-based biomaterials for applications in cardiology, dentistry, orthopedics, surgery, and urology
• Company 633 - Neurostimulation device to block residual limb pain caused by complications of amputations, as well as chronic pain after surgery, and migraine pain
• Company 634 - Joint, spine, and trauma implants
• Company 635 - "Minimally invasive" gene repair
• Company 636 - Implantable device for the surgical treatment of obesity without reliance on sutures, staples, or other mechanisms that puncture the stomach wall
• Company 637 - Microdermabrasion system with polyester/nylon bristle tips and variable vacuum levels for particle-free/crystal-free performance
• Company 638 - Elastic, self-expanding devices to specifically improve left ventricle relaxation and diastolic function
• Company 639 - Point-of-care handheld immunoassay system providing high-performance quantitative laboratory blood test results in an inexpensive, portable, and easy-to-use configuration
• Company 640 - Routine serum DNA blood tests for early cancer diagnosis and management
• Company 641 - Minimally invasive alternative to the surgical treatment of obesity
• Company 642 - Drug-eluting balloons that allow for controlled release of different and even multiple substances, for the treatment of coronary (CAD) and peripheral artery disease (PAD)
• Company 643 - Cancer prognostic tests for predicting specific individual patient clinical outcomes
• Company 644 - Genomics-based in vitro diagnostic (IVD) tests developed from FFPE tissue for personalized medicine
• Company 645 - Needleless/transdermal delivery system for insulin, analgesics, or vaccines with on/off control of dosing
• Company 646 - MRI-compatible ultrasound applicator to deliver controlled thermal therapy to the cancerous regions of the prostate gland
• Company 647 - Non-invasive (needle-free), wireless, transdermal continuous glucose monitoring (tCGM) system
• Company 648 - Antimicrobial solutions to reduce the incidence of Surgical Site Infections (SSIs) in spinal surgeries
• Company 649 - Tissue repair platform that obviates the need for sutures, stapes, glues, or other foreign bodies and instead allows the body to repair and heal itself
• Company 650 - Catheter-based system to treat large vessel acute ischemic strokes
• Company 651 - Next-generation remote patient monitoring (RPM) to continuously monitor vital life-sign functions such as: heart rate, respiratory rate, body position, activity level, and skin temperature
• Company 652 - Total Artificial Heart (TAH) to replace both ventricles of a failed heart, thus, restoring the circulatory system to normalcy
• Company 653 - Articulating range-of-motion (ROM), non-surgical spinal decompression system to treat herniated, bulged, and injured discs
• Company 654 - Portable DNA analyzers for on-demand, non-batched testing, with real-time polymerase chain reaction (PCR) results in 30-60 minutes
• Company 655 - Biomimetic hydrogel implants for spine and other orthopedic applications
• Company 656 - System designed to prevent contrast-induced nephropathy (CIN)
• Company 657 - A novel suite of workflow tools that automate the viewing, analysis, and interpretation of x-rays for musculoskeletal disease
• Company 658 - Technology to preserve the normal, healthy tissue of patients that today is damaged as a by-product of current treatments
• Company 659 - Ventricular Assist Device (VAD) that can be inserted above the diaphragm
• Company 660 - Handheld, non-invasive, real-time Central Venous Pressure (CVP) monitor for cardiology and nephrology diagnostic applications
• Company 661 - Next-generation stent platform with: significantly thin walls for reduced restenosis, ease-of-use, superior deliverability, and improved radiopacity for accurate placement
• Company 662 - In-line, battery-powered, disposable, lightweight, and completely portable blood and IV fluid warming device, capable of intravenous application and irrigation warming
• Company 663 - Next-generation endovascular devices that incorporate advanced fiber optics technology into currently used products/procedures to improve patient outcomes without adding to procedure time/cost
• Company 664 - Digital fluorescence scanners for molecular pathology research, biomarker development, and clinical molecular diagnostics (MDx) for personalized medicine
• Company 665 - Software for efficiently coordinating the delivery of patient care outside of hospitals; it optimizes home care operations and can turn a medical practice into an ACO
• Company 666 - Polymer technologies for drug delivery and regenerative medicine with applications in orthopedics and spine
• Company 667 - A-FX(TM) is a minimally invasive platform technology for creating an orthopedic implant in-situ which provides superior fixation in osteoporotic bone
• Company 668 - Non-invasive device designed to offer transcutaneous pulsed electro-magnetic field stimulation therapy for treating postoperative pain and edema in superficial soft tissue
• Company 669 - Non-invasive reverse thermal gradient technology to treat conditions of tendons, ligaments, muscles, fasciae, and joints
• Company 670 - Automatic screw delivery system for cranial maxillo-facial bone fasteners
• Company 671 - Non-invasive brain physiological measurement technologies
• Company 672 - Smallest/passive/implantable tag using RFID (radio-frequency identification) technology
• Company 673 - Diabetic pain relief via topical dermal administration and controlled release of pure Nitric Oxide (NO)
• Company 674 - A percutaneous, catheter based system for the temporary isolation of the liver from the systemic blood circulation and local administration of chemotherapy drugs at high concentrations, directly into the liver without systemic side effects - under optimal drug conditions
• Company 675 - Vacuum-based clean surface nanotechnology for faster and larger osseointegration
• Company 676 - Technology for: 1-Glaucoma diagnosis and 2-Real-time homecare monitoring of intraocular pressure (IOP)
• Company 677 - Precision stapling devices enabling minimally invasive vascular connections, especially for Coronary Artery Bypass Graft (CABG) surgery
• Company 678 - The technology, based on growth factor extract from reindeer bones, improves bone formation in bone healing problems
• Company 679 - Anteis is a Swiss company specialized in the development, manufacturing, and distribution of a range of injectable gels made from hyaluronic acid for applications in Aesthetic Dermatology, Ophthalmology, and Orthopaedics
• Company 680 - Mobile air purification unit that captures and destroys airborne pathogens
• Company 681 - Therapy delivery platform for the upper airway with applications to initially target chronic sinusitis, nasal allergies, cystic fibrosis, and CPAP users
• Company 682 - 1-Multi-generational devices using hybrid technologies for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures, 2-Low profile single-patient-use tissue retractor, 3-Range of 7Fr intra aortic balloon catheters with fluid-filled technology that plugs into current hardware
• Company 683 - Percutaneous anastomosis device to improve long-term vascular access for dialysis and cancer patients
• Company 684 - Intelligent 3DHD visualization and guidance platform for ophthalmic, cranial, and spine surgeries
• Company 685 - Wireless/battery-less antenna on a chip (tag) for continuous tracking of blood samples
• Company 686 - Permanently implanted electrical neural stimulators to treat balance/hearing/perceptual disorders
• Company 687 - Real-time advanced fluid sensing with smart solutions for safe preparation and delivery of IV medications
• Company 688 - Electrical stimulators via electrode garments for the treatment of pain related to chronic/acute soft tissue injuries
• Company 689 - Non-invasive neuromodulation technology platform to therapeutically address several major areas of disease; the Company's lead indication is Parkinson's Disease (PD)
• Company 690 - Surgical instrument designed to solve recurrent problems in managing sutures, tissue reattachment, and visualization during surgical procedures
• Company 691 - Nanolayer surface technology to improve the osteoconductive/bio-resistant/anti-infective attributes of implants
• Company 692 - 1-Biopsy needles with enhanced ultrasound visualization, 2-Microencapsulated tissue markers, 3-Devices for the local, accurately positioned, chemoablative treatment of soft tissue cancers
• Company 693 - The NuLens(TM) Dynacurve IOL is an implantable, flexible lens that changes it curvature in response with the movements of the eyes accommodative muscle system
• Company 694 - Systems to diagnose neurological and sleep disorders
• Company 695 - Technology that precisely eliminates irregularly shaped/invasive solid tumors while avoiding significant damage to surrounding healthy tissue and is non-toxic
• Company 696 - Extracellular matrix (ECM) implant that is completely integrated, remodeled, and replaced by the patient’s native tissue over time
• Company 697 - Non-surgical/injectable tissue revitalization and stabilization to address lower back pain (LBP) and the underlying problem of mechanical insufficiency
• Company 698 - 1-System for remote home patient monitoring of glucose, blood pressure, and thermal weight, 2-Glucose meter cell phone
• Company 699 - Non-invasive ophthalmic medical devices for: 1-diabetes screening and 2-daily glucose monitoring
• Company 700 - Implantable replacement valve to treat incompetent deep vein valves causing degenerative pain, swelling, and non-healing ulcers associated with chronic venous insufficiency (CVI)
• Company 701 - Advanced blood purification to reduce cytokine storm and inflammation that leads to multi-organ failure in sepsis and other critical care diseases
• Company 702 - Next-generation anatomic pathology (AP) with improved speed, automation, and ease-of-use
• Company 703 - Injectable biopolymer for the direct treatment of acute myocardial infarction (AMI)
• Company 704 - Endoear(R) is the world's first implantable hearing device of its kind, created for the treatment of mild to moderate hearing loss
• Company 705 - Wireless device for the treatment of stress/urge/mixed urinary incontinence (UI)
• Company 706 - Communication device that acquires neurological signals from the brain and translates them into speech
• Company 707 - Visually guided catheter ablation for atrial fibrillation
• Company 708 - Next-generation vessel closure
• Company 709 - Pneumatic compression devices targeted to the lymphedema, venous insufficiency, and sports medicine markets
• Company 710 - Technology that enables the "packaging" of chronic therapies/biologics in an easy-to-use, disposable patch-like device
• Company 711 - Instrumentation that provides surgeons with real-time sensing/feedback from the operative site
• Company 712 - Lab-free salt intake monitor for hypertension/congestive heart failure (CHF) patients
• Company 713 - Endoscopically placed device for the treatment of obesity
• Company 714 - Minimally invasive radiofrequency (RF) device to treat aging skin
• Company 715 - Optical biopsy needle that will accurately diagnose prostate cancer, yet eliminate random prostate biopsies
• Company 716 - New holding company for various orthopaedic device companies, such as Enztec and OMNI life science
• Company 717 - Catheters for dissolving/removing cerebral blood clots then delivering therapeutics to the diseased site
• Company 718 - Targeted molecular assays for onco-diagnostics/personalized medicine
• Company 719 - Biomarker discovery platform for detecting Type 2 Diabetes, Prostate Cancer, and Amyotrophic Lateral Sclerosis (ALS, aka Lou Gehrig's disease)
• Company 720 - Molecular diagnostic technologies for organ transplantation and various complex genetic disorders
• Company 721 - Non-invasive breast cancer diagnostic test via breast fluid analysis
• Company 722 - Non-invasive vascular disease detection that combines the advantages of MRI with the temporal resolution and ease-of-use of ultrasound
• Company 723 - Endoscopic/removable device that mimics the effects of gastric bypass surgery on a patient's metabolism
• Company 724 - "Smart" cells than can determine the type of disease/injury present in the body and repair/regenerate tissue accordingly
• Company 725 - Imaging systems for the non-invasive, in vivo detection of cancerous and pre-cancerous lesions
• Company 726 - Microarray-based technology enabling targeted next-generation sequencing of genomic regions of interest
• Company 727 - Minimally invasive therapy for Emphysema
• Company 728 - Comfortable, soft, and pliable cloth mask for the treatment of obstructive sleep apnea
• Company 729 - Wearable neuroimaging cap for mapping brain function
• Company 730 - Computer-controlled rehabilitation table for the management of lower back pain
• Company 731 - 1-Bioactive/conductive polymer materials and coatings for implantable biomedical devices and 2-Next-generation all-polymer leads that may be grown in the body
• Company 732 - Non-invasive diagnostic prenatal testing via maternal blood test
• Company 733 - Devices to treat low back pain
• Company 734 - Wearable sensor technology that safely and accurately measures individual sleep patterns
• Company 735 - Vascular navigation system designed to more accurately and rapidly position venous catheters (CVC and PICC)
• Company 736 - Minimally invasive breast tumor diagnosis and treatment
• Company 737 - Lightweight, waterproof, medical alert pendant for seniors - to avoid the dangers of missed medications
• Company 738 - Non-invasive DNA-based prenatal diagnostic test
• Company 739 - Heart pump technologies
• Company 740 - DNA sequencing technology for the detection of biomarkers for infectious and other diseases
• Company 741 - Computer-assisted surgical devices for total joint replacement
• Company 742 - Diagnostic and therapeutic ophthalmic devices
• Company 743 - Nanomaterials for angiogenesis/anti-angiogenesis/diagnostic applications
• Company 744 - Non-invasive neurostimulation device to restore vision to patients suffering from stroke, traumatic brain injury (TBI), dry age-related macular degeneration (AMD), and glaucoma
• Company 745 - Surgical/restorative dental implants
• Company 746 - Molecular diagnostic/prognostic tests for cancer
• Company 747 - Device to treat osteoarthritis
• Company 748 - Minimally invasive implant for treating spinal stenosis
• Company 749 - Non-polymeric drug-eluting stent (DES)
• Company 750 - Variety of diagnostic tests for infectious diseases, cardiology, hepatology, and various cancers
• Company 751 - Non-woven fabric with extended shelf-life to restore/repair tissue function
• Company 752 - Device for removing uterine fibroids without hysterectomy
• Company 753 - ALIVIOS Intelligent Eyewear enables people challenged with low vision to do more, including the ability to zoom in and out, improve brightness and contrast of whatever they are looking at, and even quickly store visual information for a closer look later
• Company 754 - Diagnostic retinal imaging system for use in the primary care setting
• Company 755 - Easy-to-use/automated/rapid detection of severe infectious diseases
• Company 756 - Inferior vena cava (IVC) filter that includes: 1-automatic self-centering, 2-bi-directional deployment and retrieval, 3 -atraumatic design, and 4-total transluminal filtration
• Company 757 - Compliant balloon platform technology for use in neuroradiology, cardiovascular, and peripheral vascular applications
• Company 758 - Mechanical thrombectomy device to treat ischemic stroke
• Company 759 - Artificial heart technologies
• Company 760 - Cancer diagnostic test which enables the development of personalized therapeutics
• Company 761 - Bone graft material that is: 1- synthetic, 2-non-immunogenic, 3-inclusive of all bone regenerative properties of an autograft, and 4-cost-effective
• Company 762 - Portable/rapid cooling technologies via the nasal cavity to improve patient outcomes after cardiac arrest, stroke, or traumatic brain injury (TBI)
• Company 763 - Tests for the diagnosis/prognosis of cardiovascular disease
• Company 764 - Cost-effective solutions for the improved detection and prevention of cancer in the gastrointestinal (GI) tract
• Company 765 - Neuromodulation for hypertension/heart failure
• Company 766 - System to repair abdominal aortic aneurysms (AAA)
• Company 767 - Endoscopic device to treat sinusitis
• Company 768 - Drug delivery platform that releases a cocktail of therapeutic proteins in response to a variety of local and systemic inflammatory and ischemic diseases
• Company 769 - Aortic embolic protection device for acute and long-term use
• Company 770 - Autologous adult stem cell technology, cultured from the nasal passageway, to repair damage resulting from spinal cord injury
• Company 771 - 1-Minimally invasive treatment of spinal compression, 2-Minimally invasive treatment of long bone factures, 3-Neuromodulation catheter that can be introduced into the spinal canal to treat pain
• Company 772 - Next-generation needleless drug delivery
• Company 773 - Minimally invasive neurosurgical and orthopedic instruments and implants
• Company 774 - Tissue fusion via infrared laser to replace sutures
• Company 775 - Ultrasound system that can measure true tissue elasticity in a reproducible/quantifiable/user-independent manner
• Company 776 - Next-generation nanostructured capacitors for: 1-implantable cardiac defibrillators (ICD) and 2-microsteerable cardiac ablation and related catheters
• Company 777 - Minimally invasive spine implant (facet versus pedicle screw)
• Company 778 - Spine implant that allows for post-operative adjustment of the implant size via radio control
• Company 779 - Spine fusion implant for motion preservation/dynamic stabilization
• Company 780 - Next-generation medical devices with anti-fouling surface modifications that reduce the risk of complications over long durations
• Company 781 - Device for the treatment of benign prostate hypertrophy (BPH), prostatitis, erectile dysfunction (ED), lower urinary tract symptoms, and infertility
• Company 782 - Andara technology for the treatment of acute spinal cord injury
• Company 783 - Polymer implant to repair meniscal tears via tissue regeneration
• Company 784 - Electrodes/neural interface products for functional neurosurgery and neurostimulation
• Company 785 - Non-systemic/non-invasive system that delivers magnetic versus electrical pulses for the treatment of depression
• Company 786 - Implantable neuromodulation device designed to electrically alter the pain signal pathways
• Company 787 - Next-generation implants, stem cell enabling technology, and other minimally invasive surgical instruments
• Company 788 - Invisible hearing device
• Company 789 - Cooling and compression therapy for the relief of pain/swelling after orthopedic/other surgery
• Company 790 - Catheter insertion systems, designed for extended IV dwell time, to eliminate the risk of related bloodstream infections
• Company 791 - A rapid, monthly test that uses glycated albumin to monitor gestational and type 2 diabetes more effectively
• Company 792 - Products for surgical RF ablation, valve replacement or repair, and coronary artery bypass (CABG) grafting
• Company 793 - Biomaterial with exceptional hardness/low friction/bio-inertness that also prevents the leaching of metallic ions into the body
• Company 794 - Disposable and needleless patch that can be placed on the body inconspicuously for insulin delivery - an alternative to daily insulin injections
• Company 795 - Small shunt-like device implanted into the bloodstream to modify, collect, or eliminate a broad range of Target Cells
• Company 796 - Artificial heart made of biosynthetic tissues, with two-pumps
• Company 797 - Permanently implantable/wireless/miniature sensors to transmit cardiac output, blood pressure, and heart rate data
• Company 798 - Fully implantable device for the treatment of central sleep apnea in heart failure patients
• Company 799 - Heart valve implant
• Company 800 - AdaptDx - A novel diagnostic instrument that can detect and track age-related macular degeneration (AMD) from its beginning stages, allowing for early intervention
• Company 801 - Nanotechnology-based liquid that absorbs energy on a near-molecular scale versus relying on the mechanical properties of solid materials
• Company 802 - Cyanoacrylate-based products for wound care and infection prevention
• Company 803 - Femtosecond pulse laser system for various ophthalmic applications
• Company 804 - Technology that uses the patient's own blood to make either: 1-A surgical sealant to prevent/stop bleedings or 2-A gel to stimulate the healing of chronic wounds
• Company 805 - Real-time/multi-user image communication/collaboration system that consolidates images and text records into a single point of access
• Company 806 - Polymer-based/biodegradable/drug-eluting peripheral vascular stent for tibial and infrapopliteal arteries
• Company 807 - Ultrasound-based diagnostic biosensor that enables blood analysis at the molecular level for the patient self-testing market
• Company 808 - Non-invasive biomechanical diagnostic system that records/analyzes range of motion (ROM) in a full 3-D environment for musculoskeletal diagnostics/therapeutics
• Company 809 - Full Sense(TM) Bariatric Device which is implanted and extracted via endoscopy and causes satiety leading to weight loss
• Company 810 - Continuous glucose monitoring specifically for use in the Intensive Care Unit (ICU)
• Company 811 - Real-time interactive training visualization system, specifically for the task of training any designated personnel in successfully accomplishing a limited "focused assessment with sonography for trauma" (FAST) examination
• Company 812 - Molecular diagnostic tests to: 1-Differentiate between squamous and non-squamous non-small-cell lung cancer, 2-Differentiate between mesothelioma and adenocarcinoma, 3-Identify more than 20 types of cancer
• Company 813 - Nasal stent to treat obstructive sleep apnea
• Company 814 - 1-Pacing/sensor-enabled device for Cardiac Resynchronization Therapy (CRT), 2-Real-time modality to quantify cardiac performance, 3-System that adds ingestible microchips to drugs
• Company 815 - Pocket-sized, affordable, and easy-to-use resuscitation devices that can be effectively deployed by both trained professionals and laymen
• Company 816 - Wearable health monitoring system for potential diabetes, heart disease, and sleep apnea applications
• Company 817 - Biomarkers for the screening and diagnosis of cervical and other cancers
• Company 818 - Implantable vagus nerve stimulation system for the treatment of tinnitus and post-stroke motor rehabilitation
• Company 819 - Smart, accurate guiding device based on image technology for orthopedic trauma procedures such internal fixation with intramedullary (IM) nails, osteotomy, and others
• Company 820 - Non-invasive molecular diagnostics for autism, chronic obstructive pulmonary disease (COPD), multiple sclerosis, and diseases with a genetic susceptibility
• Company 821 - Natural polymer technology that mimics the physiological clotting cascade without reliance on blood-derived proteins - to stop severe bleeding, reinforce staple and suture lines, and repair tissues
• Company 822 - Effective and convenient phototherapy system available for in-home treatment of scalp/small-area psoriasis and other photo-responsive skin diseases
• Company 823 - Electroporation-delivered/DNA-based vaccines against cancers and infectious diseases
• Company 824 - Next-generation computer-assisted laparoscopic tool composed of multiple rigid elements with intervening controllable joints
• Company 825 - Low-cost/point-of-care (POC) analyzer to quantify hemostasis in whole blood, including cellular and plasma components
• Company 826 - Fluorescent markers/optical sensors that provide an accurate and rapid determination of kidney function
• Company 827 - Ready-to-market medical device for assessing - via the eye - exposure to neurotoxins, cyanide, and low level radiation. Future products include assessment of mild TBI and other health conditions, including diabetic diseases of the eye.
• Company 828 - The SatiSphere System is a non-invasive obesity device that safely and effectively uses the body's natural physiology to treat obesity by regulating satiation mechanisms, slowing digestion, and discouraging excessive eating
• Company 829 - Catheter ablation for the treatment of cardiac arrhythmias
• Company 830 - Monitoring products/clinical services for advanced ambulatory cardiac monitoring
• Company 831 - Technology used in: 1-Finished products designed for micro-surgical/microscopy procedures and robotics and 2-Biosensors with applications in gene expression, neuroscience, and nanotechnology
• Company 832 - Resorbable hydrogel that 1-Seals annular tears in the intervertebral disc and 2-Provides an environment for nucleus regeneration
• Company 833 - Non-invasive/fast/easy-to-use/reliable medical devices that test for neuro-visual disorders
• Company 834 - High-dose drug delivery system for the minimally invasive and repeatable treatment of liver cancers, colorectal cancer, and hepatitis
• Company 835 - Technologies that integrate bone and cartilage forming peptide and small molecule therapies with osteostimulating matrices
• Company 836 - A non-invasive, safe cardiac diagnostic system that in a 10-minute test reliably detects existence or absence of ischemia and monitors treatment efficacy
• Company 837 - Injectable porous scaffolds/spheres/composites with fully interconnected pores, for multiple applications
• Company 838 - Compact, remote, wireless, real-time device for biomedical monitoring such as cardiac, neurological, sleep disorder, obstetrics, orthopedic, and other vital signs outside the hospital/clinic
• Company 839 - Permanent implant to address mitral regurgitation directly
• Company 840 - Portable/lab-quality diagnostics for the ER/ambulance/physician's office/home/field
• Company 841 - Percutaneous injection treatment for patients with internal disc derangement (IDD) who have failed conservative care/are not yet candidates for total disc replacement (TDR)/spinal fusion
• Company 842 - Technology that allows surgeons to rapidly treat tissue at the surgical site/reduce blood loss
• Company 843 - A1c diabetes testing at the point of care, with results in under 4 minutes
• Company 844 - Next- generation/predictive blood tests to help warn of potential future health problems
• Company 845 - Vertebral compression fracture treatment
• Company 846 - Orthopedic imaging
• Company 847 - 1-Artificial vascular graft with self-sealing, non-woven, synthetic fiber structure, 2-Ventral hernia mesh
• Company 848 - 1-Prohealing coronary stent as an alternative to drug-eluting stents (DES), 2-Balloon -expandable/crush-resistant nitinol peripheral stent, 3-Nano-based transcatheter, 4-Anatomy-specific combination embolic protection and stent delivery systems, 5-Localiz
• Company 849 - Early detection of Alzheimer's disease via an eye drop and laser eye scan
• Company 850 - Drug-coated balloon angioplasty technology
• Company 851 - Behavioral remote patient monitoring system that uses wireless sensors to non-intrusively track and report on the daily patterns of seniors' activities
• Company 852 - System that assesses, then provides therapy to develop infant feeding skills
• Company 853 - Painless, continuous glucose monitoring
• Company 854 - Wireless/wearable/ultra-compact device that automatically tracks/wirelessly uploads data about a person's activities (exercise intensity levels, calories burned, sleep quality, steps, distance)
• Company 855 - Joint reconstruction device that ideally/anatomically matches the size/shape of the facet joint
• Company 856 - Platforms for: 1- Pedicle screw fixation (even with poor bone quality), 2-Vertebral compression fractures, 3-Simple- to-use trauma products
• Company 857 - Implantable device for maintaining adequate blood flow to the brain in patients experiencing a buildup of excess cerebral spinal fluid (CSF) due to trauma
• Company 858 - 1- Straightforward knotless suture anchor, 2-Instrumentation for percutaneous suture management, 3- Endotendonous repair system, 4-Shape memory staples
• Company 859 - Coagulation analyzer to eliminate unnecessary blood transfusions
• Company 860 - Simple, rapid, blood-based cancer tests to provide accurate and individualized clinical information on disease status/treatment selection/treatment response
• Company 861 - Neurostimulator for cardiac contractility
• Company 862 - Endoscopically delivered devices focused on slowing gastric emptying, to treat all stages of obesity
• Company 863 - Autonomic nervous system stimulation for pulmonary and headache disorders
• Company 864 - Optimization of T cell receptors (TCRs) for use in adoptive T cell therapy - to target and destroy cancerous/infected cells
• Company 865 - Technology for wound care and slow release drug delivery, by both transdermal and subcutaneous routes
• Company 866 - Intraoperative wavefront aberrometer for use in intraocular lens replacement surgeries
• Company 867 - Technology to treat atrial fibrillation that allows doctors to perform radiofrequency ablation under direct visualization
• Company 868 - Tests to "predict" chronic diseases/conditions, such as diabetes/osteoporotic bone fracture/a major cardiac event
• Company 869 - Disposable/miniature/minimally invasive surgical devices including reusable endoscopes for visualization, initially for use in spinal surgeries
• Company 870 - Dental implant that can be placed into a multi-rooted molar extraction site "immediately"
• Company 871 - Biocompatible and biodegradable synthetic scaffold to aid soft tissue regeneration of the anterior cruciate ligament (ACL) of the knee
• Company 872 - Ingestible/wireless capsule with sensor technology to measure pH, pressure and temperature from within the entire GI tract
• Company 873 - Counter-stimulation technology to treat Restless Legs Syndrome (RLS)
• Company 874 - Minimally invasive device to treat emphysema
• Company 875 - Gene expression test for the diagnosis of ambiguous tumors
• Company 876 - Ocular metabolic imaging to "predict" eye diseases, including diabetic retinopathy/glaucoma/age-related macular degeneration
• Company 877 - Implantable neuromodulation device for the treatment of chronic pain and future applications
• Company 878 - Home-use devices for hair removal/acne/skin rejuvenation
• Company 879 - Technology that restores natural physiologic outflow as a foundation of significant/steady/sustained glaucoma management
• Company 880 - Minimally invasive surgery system for simpler and safer soft-tissue suturing/fastening
• Company 881 - Effective/consistent/non-invasive neuromodulation for the treatment of urinary incontinence and future applications
• Company 882 - 1-Needleless mesotherapy to treat cellulite, 2-Non-invasive/non-thermal treatment for skin laxity/hypertrophic scars/striae
• Company 883 - Laparoscopic instruments that articulate/rotate/lock for single port access/"scar-less" surgery
• Company 884 - Miniature implantable sensors to accurately/continuously pinpoint the location of tumors in real-time, during radiation therapy delivery
• Company 885 - Manual rongeur and access tools for use in spinal decompression procedures
• Company 886 - Convenient/improved continuous glucose monitoring system
• Company 887 - Coating that triggers the body to generate nitric oxide (NO) at the device surface, by using naturally circulating blood substances
• Company 888 - Real-time/in vivo/cellular-level/3-D imaging for: image-guided surgery; early cancer diagnosis without a biopsy
• Company 889 - In vivo transdifferentiation to regenerate ischemic/diseased organs
• Company 890 - Oxygen metabolic imaging bioscale (TVI-agents) which are injected intravenously prior to imaging in a standard MRI scanner
• Company 891 - True seizure "prediction" - up to an hour before the event
• Company 892 - Wearable mobile device to accurately measure real-time energy (calorie) expenditure/combat obesity
• Company 893 - 1-Non-embryonic cell technology that creates cells/tissues/organs for virtually anyone needing a transplant, 2-Non-toxic cancer vaccine that uses the body's natural immune response to fight cancer, 3-Cell separation system to diagnose/monitor cancer
• Company 894 - Custom miniaturized mechanical components/devices for a broad range of medical device applications
• Company 895 - Wireless/disposable sleep-monitoring device
• Company 896 - 1-Next-generation, natural fibrin sealant, 2-Human thrombin
• Company 897 - In vivo smart sensor to help women get pregnant, automatically detecting pregnancy and any early pregnancy loss, and screening for cervical cancer and other STDs, with additional uses central to women's health & lifestyle
• Company 898 - Technologies that focus on wound diagnostics, infection control, and wound therapy
• Company 899 - Wireless/MEMS-fabricated/nano-processed/dermal/percutaneous continuous glucose monitoring device
• Company 900 - Diagnostic instrument to measure the material properties of bone
• Company 901 - Electronic Brachytherapy (eBx) systems based upon miniaturized x-ray tube technology for the practice of radiation oncology in virtually any clinical setting, eliminating the need for heavily shielded environments
• Company 902 - Minimally invasive method for lumbar spine decompression to treat patients with lumbar spinal stenosis (LSS), which may be performed in conventional operating rooms or interventional radiology suites with fluoroscopic imaging
• Company 903 - Next-generation respiratory device that delivers synchronization of flow/temperature/humidity/oxygen percentage, without discomfort, via nasal cannula
• Company 904 - Minimally invasive system to treat emphysema and resolve prolonged air leaks following lung surgery
• Company 905 - 3-D mesh pouches that are implanted empty, positioned, filled, then deployed to their full size for spinal/orthopedic applications
• Company 906 - Painless photo-pulsation technology for diminishing fine lines/wrinkles/age spots on the face/neck/hands
• Company 907 - Plastic surgery implantable devices for cosmetic and reconstructive surgery
• Company 908 - The SENSIMED Triggerfish(R) "eye-Holter" is a paradigm-changing technology consisting of a disposable contact lens telemetric sensor, which for the first time provides ophthalmologists with the full ambulatory 24-hour IOP profile, conveniently and during uninterrupted daily activities and sleep
• Company 909 - Technology for the non-fusion treatment of scoliosis
• Company 910 - Atraumatic injectable plugs for 1-Temporary occlusion of blood vessels, 2-Kidney stone removal, and 3-future applications
• Company 911 - Percutaneously deliverable endograft to treat Abdominal Aortic Aneurysms (AAA) and Thoracic Aortic Aneurysms (TAA)
• Company 912 - Optical Coherence Tomography (OCT) for sub-surface biological tissue imaging at much greater resolution than ultrasound/MRI/CT scanners
• Company 913 - Next-generation femtosecond laser that can operate inside the eye to make cataract surgery safer/more effective
• Company 914 - Totally implantable pumps delivering targeted medications directly to the spinal cord
• Company 915 - Point-of-care diagnostic tests for infectious diseases capable of detecting virulence markers produced only during ACTIVE infections
• Company 916 - Therapeutic gene delivery
• Company 917 - 1-Vertebral augmentation system and 2-On-demand ultra-high viscosity cement injection, for spinal applications
• Company 918 - Miniature implantable neurostimulator for treating central nervous system disorders
• Company 919 - Simple, point-of-care blood test for the detection/monitoring of traumatic brain injury (TBI)
• Company 920 - Resurfacing system to treat lesions/defects in the body's weight bearing, non-weight bearing, and extremity joints
• Company 921 - Molecular imaging of apoptosis (programmed cell death) for disease detection/monitoring
• Company 922 - Technology to close incisions made during Natural Orifice Transluminal Endoscopic Surgery (NOTES) procedures
• Company 923 - Transitional in vivo imaging
• Company 924 - Collapsible titanium-alloy implant for spinal fusion
• Company 925 - Non-invasive type 2 diabetes and pre-diabetes screening with no blood draw/no fasting/no waiting for a lab result
• Company 926 - Devices for the destruction of pathogens responsible for: heart/blood/respiratory/gastrointestinal/periodontal/otological diseases, pancreatic cancer, and toe nail fungus
• Company 927 - Device that delivers a low-level/precisely controlled heat for the treatment of acne
• Company 928 - Nanomaterial-based MRI coil for higher image quality/faster scan times
• Company 929 - Handheld/at-home hair removal via laser
• Company 930 - Enhanced diabetes insulin pump
• Company 931 - Transpedicular/minimally invasive approach to vertebral body reconstruction/anterior spinal column support
• Company 932 - Next-generation Spinal Cord Stimulation (SCS) technology to treat chronic back/lower extremity pain
• Company 933 - Dynamic and intelligent optics for use in spectacle lenses for the correction of presbyopia
• Company 934 - Blood screening tests for breast and ovarian cancers
• Company 935 - Implantable/battery-less diagnostic system to allow orthopedic surgeons to monitor spinal fusion progress
• Company 936 - Next-generation coatings/advanced drug-delivery systems for cardiovascular stents and other implantable medical devices
• Company 937 - Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) device for acute coronary syndrome (ACS) and heart failure patients
• Company 938 - Ultra-thin/personalized/single-use/flexible/transdermal drug delivery patch
• Company 939 - DNA-based diagnostic tests for early identification/management of cancer/acute diseases
• Company 940 - Device with bio-active formulae to rapidly/painlessly treat/control the wound environment
• Company 941 - Less invasive treatment for chronic sinusitis delivered via non-nasal access
• Company 942 - Leadless/implantable pacing device for left ventricular stimulation/the treatment of heart failure
• Company 943 - Technologies to acquire/process/visualize data from 3-D breast imaging
• Company 944 - Mental stimulation system to help maintain mental acuity/quality of life
• Company 945 - Implantable device to treat high blood pressure that cannot be controlled with medications/lifestyle modifications
• Company 946 - Polymer technologies for cardiac/cranio-maxillofacial/orthopedic surgery applications
• Company 947 - Leadless/subcutaneously implantable cardiac defibrillator (ICD)
• Company 948 - 1-Handheld intelligent bone sculpting tool, 2-X-ray vision that appears "within" the patient
• Company 949 - Synthetic peptides for tissue regeneration for the treatment of musculoskeletal/vascular/chronic wound diseases
• Company 950 - Radiofrequency (RF) energy to reshape the cornea without incision
• Company 951 - Endovascular treatment of peripheral arterial blood vessels that require re-vascularization
• Company 952 - Cells derived from bone marrow which can be used in an allogeneic/off-the-shelf setting to treat kidney/other difficult to treat diseases
• Company 953 - Thin-walled/removable/entirely covered stents designed to match the site to be treated and the surrounding anatomy
• Company 954 - Technologies to: 1-Treat the progression of age-related macular degeneration (AMD) and retinitis pigmentosa (RP), 2-Stop/reverse some of the vision loss from Glaucoma, 3-Prevent diabetic retinopathy, 4-Greatly enhance pars plana vitrectomy surgery
• Company 955 - Single device for high-frequency ultrasound imaging/therapeutic treatment
• Company 956 - Low-level laser technology for aesthetics, bone healing, neck/shoulder pain, and wound healing
• Company 957 - Light-based aesthetic systems that are pain-free/seven times faster than existing systems
• Company 958 - 1-Image analysis technology for virus detection/analysis, 2-Antiviral drugs
• Company 959 - Simultaneous testing of sobriety and identy that is simple/rapid/non-invasive, requiring no bodily fluids
• Company 960 - Technology for diagnosing breast and ovarian cancers and determining responsiveness to new therapeutics
• Company 961 - Synthetic graft/stent technology that reduces neo-intimal hyperplasia (NIH) and occurrence/rate of restenosis
• Company 962 - Disposable endoscopic assist device that can be used with existing equipment to significantly improve flexible endoscopy procedures
• Company 963 - Systems using radiofrequency (RF) energy for the treatment of GERD and fecal incontinence (FI)
• Company 964 - Sutureless anastomosis systems to reduce/eliminate cross clamping time and suturing during minimally invasive surgery (MIS)
• Company 965 - Anti-infective compounds designed to mimic host defense proteins, but with completely synthetic/non-peptide backbones, for serious, life-threatening, acute disorders
• Company 966 - Minimally invasive interstitial laser therapy (ILT) as an alternative to lumpectomy
• Company 967 - Less invasive approach for mitral valve repair, on a beating heart
• Company 968 - High-resolution dermoscopy imaging technology to identify melanoma at an earlier stage/reduce the number of unnecessary excisions
• Company 969 - Nanotechnology surface treatments for combination medical devices that address nosocomial (in-hospital) infections and thrombus
• Company 970 - Non-invasive, fully automated system for the accurate assessment of: cardiovascular/diabetic autonomic neuropathy, effectiveness of beta-blocker therapy, and risk stratification of sudden cardiac death
• Company 971 - Wireless/motorized orthopedic lengthening implants for applications in deformity correction/cosmetic limb lengthening/bone fractures
• Company 972 - 3-D scaffold that enhances the biointegration of percutaneous/fully implanted current and next-generation devices
• Company 973 - Injectable gels for localized and controlled release of biologicals
• Company 974 - Portable/palm-held endoscopic imaging with a mobile platform for recording/sharing/archiving images
• Company 975 - Hand-held ultrasound device to quantify strain and stiffness of tendons/ligaments
• Company 976 - Lightweight brace support suit that restores mobility function for paraplegics/lower limb paralysis patients
• Company 977 - Non-invasive gene expression-based tests for the monitoring of transplant rejection/autoimmune diseases
• Company 978 - Cobalt-chromium, balloon-expandable stent, which marries with approved DES to treat the entire spectrum of coronary artery bifurcation lesions
• Company 979 - Non-invasive intracranial pressure monitor to diagnose/treat head injury
• Company 980 - Temperature-controlled/multi-functional next-generation cutting/sealing product
• Company 981 - Interspinous/interlaminar functionally dynamic stabilization device and other non-fusion scoliosis technologies
• Company 982 - CO2 lasers through flexible/rigid endoscopes for use in minimally invasive surgery and soft tissue procedures in otolaryngology/head and neck surgery/pulmonology
• Company 983 - Real-time/PCR-based molecular diagnostic tests for life-threatening respiratory fungal infections
• Company 984 - Ultra-lightweight/soft/non-palpable mesh technology to treat urinary stress incontinence/pelvic organ prolapse
• Company 985 - Medipacs first-ever, solid-state polymer pump platform is the "end-game" for low cost, high precision drug delivery solutions and it will spawn electronic syringe products that reformulate markets
• Company 986 - Surgical implants and biological products for spinal surgery
• Company 987 - In situ formed hydrogels designed/indicated for ophthalmic surgery
• Company 988 - Light-activated glue system to stabilize shattered bone
• Company 989 - Non-contact imaging system that provides local anatomical and oxygenation information
• Company 990 - Affordable/good quality standard-of-care surgical devices
• Company 991 - Low-dose-rate brachytherapy that will replace individual seeds and provide more uniform/consistent radiation delivery to patients
• Company 992 - Recombinant adeno-associated viral (AAV)-based gene therapy as a treatment for congestive heart failure (CHF)
• Company 993 - Aortic valve bypass graft system for use as a minimally invasive, beating heart alternative to traditional aortic valve replacement therapy
• Company 994 - Single-use catheter device w/controller that delivers radiofrequency energy during outpatient bronchial thermoplasty for the treatment of asthma
• Company 995 - Ultrasonic energy for the selective dissection/fragmentation/debridement/cleansing of tissues
• Company 996 - Percutaneous soft tissue lifts for the breast/neck/other soft tissue structures
• Company 997 - Bioresorbable polymer surgical implants designed to prevent/reduce the formation of post-operative adhesions
• Company 998 - Implanted electronic subretinal device to restore vision to those who are blind due to retinitis pigmentosa (RP) or age-related macular degeneration (AMD)
• Company 999 - Noninvasive tests for the risk assessment of cardiovascular disease and the detection of early-stage lung/breast/colorectal cancer
• Company 1000 - Guidewire system intended to safely/quickly cross occluded peripheral and coronary vessels
• Company 1001 - Matrix therapy based technology that treats skin ulcers/reduces amputation
• Company 1002 - Artificial muscle technology for the treatment of sphincter dysfunction and urinary incontinence (UI)
• Company 1003 - Technology that selectively treats only cancer cells and avoids destruction of normal cells
• Company 1004 - Full line of precision-crafted/disposable/ultra-minimally invasive surgical instruments
• Company 1005 - Beam steering/target tracking/treatment planning solutions to the external beam radiation therapy market
• Company 1006 - Device that uses combined electric field and low-intensity, noninvasive ultrasound for the treatment of solid tumors without the need for chemotherapy
• Company 1007 - One-shot, instantaneous anastomotic stapling devices for open AAA, EVAR, and CLI applications
• Company 1008 - Stent to treat cerebral/aortic aneurysms by modulating hemodynamic flow
• Company 1009 - Biomotion sensors that enable easy/non-contact capture of high-quality physiological data - remotely/wirelessly
• Company 1010 - Flexible/single-use/sterile video-endoscopes which may be used at the patient bedside and which avoid all cross-contamination risks
• Company 1011 - Therapeutic gene delivery to treat diabetes/obesity/intestinal disorders/hemophilia/anemia
• Company 1012 - Non-invasive technique for sampling the surface layers of the skin to generate individual genetic profiles for diagnostic/prognostics
• Company 1013 - Non-invasive method designed to only kill fat cells and not harm the skin or other tissue
• Company 1014 - 3-D/single-piece/dual optic accommodating intraocular lens (IOL)
• Company 1015 - Cellular therapy to act directly at the level of the cause of autoimmune disorders, the dysregulated immune regulation
• Company 1016 - Next-generation transluminally placed endovascular grafts for the treatment of aneurysmal disease in the AAA/TAA
• Company 1017 - Real-time endoscopic tissue imaging system for high-resolution visualization of bronchial/pulmonary tissue cross-sections without biopsy
• Company 1018 - Very strong/customizable/biomimetic/easily revisable artificial disc implant, requiring no assembly in situ
• Company 1019 - Diagnostic and therapeutic catheter-based devices for prevention/treatment of heart attacks caused by soft plaque
• Company 1020 - Advanced method of photocoagulation to provide more rapid, precise, and safe treatment for a variety of retinal conditions
• Company 1021 - Next-generation personal diagnostics for hematological malignancies/autoimmune disorders
• Company 1022 - Soft tissue repair/replacement, using proprietary chemistry and organic collagen matrices
• Company 1023 - Sirolimus-based product as a next-generation therapeutic for the treatment/prevention of wet AMD and the treatment of diabetic macular edema
• Company 1024 - Phototherapy/ultraviolet light to inactivate the organisms that cause nail infections
• Company 1025 - Technology enabling detection and monitoring wirelessly, remotely, and with no contact to the subjects; also through clothing/barriers
• Company 1026 - Biochips to identify gene expression patterns
• Company 1027 - Automated blood analysis at point-of-care
• Company 1028 - Applicator for breast brachytherapy that delivers targeted dose of radiation
• Company 1029 - MRI contrast agents to monitor the position/quantity of transplanted cells non-invasively in vivo
• Company 1030 - A soft tissue aperture fixation system for anterior cruciate ligament (ACL) reconstruction using the hamstring/other soft tissue grafts
• Company 1031 - Non-invasive/convenient measurement and monitoring of human hydration status, using saliva as a sample
• Company 1032 - Cryotherapy to ablate diseased tissue
• Company 1033 - Reliable/accurate/solid-state laser system for customized treatment of many vision disorders
• Company 1034 - Non-invasive/iontophoretic drug delivery system with broad applicability for treating serious ocular diseases
• Company 1035 - Electrical stimulation technology, along with single-use disposables, to restore continence control to individuals with abdominal ostomies and eliminate the need for traditional ostomy pouching systems
• Company 1036 - MRI-guided laser ablation system for targeted, minimally invasive, focal tumor therapy
• Company 1037 - Medical devices that enable earlier detection/minimally invasive treatment of lung cancer
• Company 1038 - Non-invasive devices for the treatment of superficial venous disease
• Company 1039 - Truly minimally invasive or open system utilizing a proprietary uni-axial screw at one-half the cost of poly-axial systems for all spine disorders
• Company 1040 - 1-Catheter-based system for the treatment of ischemic brain injury; 2-Drug delivery systems; 3-Microcatheters; and 4-Aneurysm coil delivery systems
• Company 1041 - Cardiac assist device for patients in moderate/severe long-term heart failure
• Company 1042 - Digital image acquisition, coupled with proprietary CAD decision-making algorithms, to provide an immediate/automated colposcopic evaluation
• Company 1043 - Robotic system for fabrication of nano-material based wound dressings, delivered on-demand, at the POC
• Company 1044 - Unique spine functional testing that delivers improved surgical outcomes
• Company 1045 - Electromagnetic thermal therapy to relieve pain/improve function in patients suffering from osteoarthritis
• Company 1046 - System to inactivate pathogens in all three major blood components: platelets/plasma/red cells
• Company 1047 - Therapeutic approaches to prevent the abnormal tissue growth that inhibits recovery from surgical procedures/impairs normal wound healing
• Company 1048 - Biocompatible shape memory polymers which can be programmed to change shapes/rigidity when an initiating stimulus is applied
• Company 1049 - A fully integrated, affordable, sample-to-result platform for rapid, accurate PCR-based detection/differentiation of infectious disease
• Company 1050 - Technologies that will prevent infection for many large patient populations
• Company 1051 - Light-activated drug therapy to transform cancer into a treatable chronic disease
• Company 1052 - 1-Percutaneous venous valve, 2-Inferior vena cava filter, 3-Multi-purpose/disposable laparoscopic scissor grasper, 4-Multi-sized/multi-stiffness guidewire
• Company 1053 - Non-invasive infrared imaging system for the early detection of breast cancer
• Company 1054 - Device for the treatment of sudden cardiac arrest for both in- and out-of-hospital markets
• Company 1055 - Line of antimicrobial coatings to prevent microbial colonization/biofilm formation of endotracheal tubes/other indwelling medical devices
• Company 1056 - 3-D tracking devices for use in surgical navigation and MIS
• Company 1057 - Implantable patient alerting system for the detection and prevention of heart attacks
• Company 1058 - Minimally invasive/RF nerve ablation to reduce of migraine headache pain
• Company 1059 - Less invasive devices for the treatment of glaucoma, intended to replace current therapies
• Company 1060 - Natural cell-based technologies to restore normal neuron function in the central nervous system
• Company 1061 - Non-invasive/urine-based diagnostic assays for specific cancer types
• Company 1062 - Fluid-controlled accommodating intraocular lens (IOL) to restore vision of youth to middle-aged/elderly individuals
• Company 1063 - Single, multi-cannula laparoscopic port and specially designed curved instrumentation
• Company 1064 - Technology that provides the precision of a scalpel and the bleeding control of traditional electrosurgery, without extensive collateral tissue damage
• Company 1065 - More viable/cost-effective method for treating intracranial aneurysms
• Company 1066 - System that enables consistent tissue contact/complete lesions during cardiac surgery for the treatment of arrhythmias
• Company 1067 - Non-invasive neurorehabilitation system
• Company 1068 - Cerebral protection system to prevent embolic strokes
• Company 1069 - Catheter-based drug delivery using high-frequency/low-power ultrasound
• Company 1070 - Technology for real-time identification/localization of cancer cell clusters to enable complete/residual-free therapeutic excisions
• Company 1071 - Third-generation cancer-associated biomarkers using proteomics
• Company 1072 - Cardiac mapping system that is non-invasive, maps the entire heart in one beat, and provides catheter localization
• Company 1073 - Repair and regeneration technology platforms designed to mend and regrow hard tissue (such as bone) and soft tissue (such as cartilage)
• Company 1074 - Minimally invasive/flexible spinal implant technology to treat vertebral compression fractures and degenerative disc disease
• Company 1075 - Catheter-based drug delivery system designed to dissolve blood clots in a single/rapid/one-step procedure
• Company 1076 - Rapid DNA-based point-of-care diagnostics
• Company 1077 - Joint prostheses as an adjunct to laminectomy/laminotomy/neural decompression/facetectomy, in lieu of fusion
• Company 1078 - Advanced trilobal pericardial valve technologies
• Company 1079 - Protective coatings for medical instrumentation to combat bacterial biofilms
• Company 1080 - Wireless ECG monitoring
• Company 1081 - De-cellularized biological scaffolds meant to function like native tissue
• Company 1082 - Non-invasive, wearable, watch-sized metabolism measurement system that employs the use of a low-cost proprietary disposable sensor using direct-calorimetry, to accurately measure minute-by-minute caloric expenditures
• Company 1083 - Advanced, intuitive real-time imaging for abdominal minimally invasive surgery
• Company 1084 - Technology that improves vascular access accuracy and visualization of veins and arteries as well as related vascular events such as rolled veins, bifurcations, vasospasm, and extravasation
• Company 1085 - Regenerative medicine company developing novel treatments from hair growth to cancer therapies based on the products of cells grown under simulated embryonic conditions
• Company 1086 - Next-generation cell-based/tissue-engineered products
• Company 1087 - Mesh wrap for permanent implantation around the heart to prevent/reverse the progression of heart failure
• Company 1088 - Handheld/breath-based blood glucose monitor
• Company 1089 - More targeted/accurate radiation of cancer cells with significantly fewer side-effects
• Company 1090 - Bioactive glass-ceramic material that offers whiter and less-sensitive teeth while protecting from tooth decay
• Company 1091 - Membrane optimization, coatings technologies, and development of polymers for biomedical applications
• Company 1092 - System to process/concentrate cellular components from autologous bone marrow, including adult stem cells, at the point-of-care and in just 15 minutes
• Company 1093 - Devices to control bleeding post-hysterectomy/in other cases of pelvic area trauma
• Company 1094 - Safe, non-invasive body shaping technologies
• Company 1095 - Non-invasive/fast/accurate diagnostic kits for: fertility, hormones, infectious agents, auto-antibodies, and tumor markers
• Company 1096 - Gene therapy products for the treatment of inherited/acquired diseases.
• Company 1097 - Stent technology for the treatment of atherosclerotic disease at/near bifurcations
• Company 1098 - Neo-organs/tissues derived from the patient's own (autologous) cells
• Company 1099 - Computer-controlled pressure garments for the effective treatment of lymphedema/chronic wound healing
• Company 1100 - Small/portable/disposable infusion pump kit to treat post-operative pain more effectively than narcotics
• Company 1101 - Pulsatile perfusion generator technology to greatly enhance the preservation time window and organ transplant quality
• Company 1102 - Second-generation electronic retinal implant to treat blindness due to retinitis pigmentosa
• Company 1103 - Device to improve drainage following heart, lung, and trauma surgery, as well as other procedures where drainage is critical
• Company 1104 - Next-generation/fully-automated/electronically-controlled/self-contained blood glucose system
• Company 1105 - Minimally invasive system for treating long-bone fractures using an intermedullary stent/cement
• Company 1106 - Non-invasive measurement of magnetic fields to diagnose functional brain disorders
• Company 1107 - Products to diagnose/treat dry and wet age-related macular degeneration (AMD) and other chronic diseases involving the alternative complement system
• Company 1108 - Wearable artificial kidney device
• Company 1109 - Multi-generational devices using hybrid technologies for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
• Company 1110 - Miniature patch that dispenses insulin
• Company 1111 - Microcatheter and imaging technologies for interventional ophthalmology
• Company 1112 - Easy, safe, and convenient injection of drugs and vaccines in a solid dosage form using the Glide SDI(R) (Solid Dose Injector)
• Company 1113 - Non-epigenetic cell reprogramming technology that enables the generation of patient-identical replacement tissue/organs on an as-needed basis
• Company 1114 - Device to percutaneously repair the mitral valve
• Company 1115 - Miniature intravascular flow augmentation device for every organ that needs temporary change of flow
• Company 1116 - Minimally invasive surgical procedure intended to reduce the incidence of stroke/thromboembolism associated with atrial fibrillation
• Company 1117 - Plaque vulnerability biomarkers to detect patients at risk for the development of stroke, myocardial infarction or claudication
• Company 1118 - A platform for minimally-invasive cardiac surgery (MICS) via single-port, subxiphoid access, and an endoscope that reaches any anatomical location, including complex paths, from one single access port
• Company 1119 - Percutaneous mitral valve replacement (PMVR) for Mitral Regurgitation (MR)
• Company 1120 - Medical devices for the osteoarthritis/rhinosinusitis markets
• Company 1121 - Miniaturized ultrasound probe that is easier-to-use/more flexible
• Company 1122 - Resonating sensor made out of piezoelectric ceramics that can be miniaturized and is suitable for use in diagnostic equipment
• Company 1123 - Bioresorbable peripheral/coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty
• Company 1124 - Disposable devices for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
• Company 1125 - True 3-D imaging to improve evaluation/planning of radiation treatments
• Company 1126 - Next-generation spinal implants
• Company 1127 - New unilateral posterior fusion technology
• Company 1128 - Products for nuclear replacement/augmentation, vertebral compression fracture repair, and spinal fusion
• Company 1129 - Second-generation, metal-on-metal cervical/lumbar artificial discs
• Company 1130 - Artificial cervical disc with controlled range of motion in all six degrees of freedom
• Company 1131 - Next-generation of biomaterials for spinal implants
• Company 1132 - Intradiscal arthroplasty device utilizing articulating PEEK-on-PEEK material
• Company 1133 - Hydrogel matrix with applications across multiple specialties
• Company 1134 - Intelligent microgels as injectable scaffolds for intervertebral disc repair
• Company 1135 - Minimally invasive disc augmentation system to repair/rehabilitate an intervertebral disc
• Company 1136 - Implant designed to retain motion following the removal of diseased disc and/or bone material in the upper spine
• Company 1137 - Tissue repair/surgical mesh systems for soft tissue repair
• Company 1138 - Silicon nitride implants with 3-D structured cancellous ceramic for strong capillary action
• Company 1139 - Tibial knee implant for stable fixation to the medial tibial plateau without bone cuts/cement/screws
• Company 1140 - Technologies to treat obstructive sleep apnea and snoring
• Company 1141 - Anatomically-driven/minimally invasive spinal products for motion preservation
• Company 1142 - Tissue engineering technologies for orthopedic/sports medicine patients
• Company 1143 - Real-time imaging/image guidance for the operating room
• Company 1144 - Stent that provides protection from embolic showers during/post-procedure
• Company 1145 - Minimally invasive vapor technology to treat emphysema
• Company 1146 - Human-based tissue scaffolds
• Company 1147 - Simple, low-cost infusion pump that contains the IV bag within it
• Company 1148 - Non-intrusive patient-monitoring systems that facilitate timely intervention for cardiac/respiratory deterioration
• Company 1149 - Bifurcated stenting
• Company 1150 - Bioabsorbable implants for accurate soft tissue fixation either to apposing soft tissue/to bone
• Company 1151 - Drug delivery vehicles that can easily be targeted to specific cell types/disease state tissues
• Company 1152 - Minimally invasive therapies for interventional neuroradiology
• Company 1153 - Treatment for ischemia via stem cell-based therapies
• Company 1154 - Cellular therapy device to treat liver disease
• Company 1155 - Customizable vibration therapy devices to stimulate bone/muscle tissue
• Company 1156 - Deep brain stimulation (DBS) guidance system
• Company 1157 - Cellular imaging technology, using the Internet to transfer real-time/secure/accurate cellular resolution images
• Company 1158 - Minimally-invasive percutaneous aortic valve replacement systems
• Company 1159 - Off-the-shelf implantable allograft tissue to support peripheral nerve repair and regeneration
• Company 1160 - Advanced detection, staging, endoscopic treatment and follow-up care for acute and chronic lung disease
• Company 1161 - Minimally invasive therapy for the treatment of chronic disc pain
• Company 1162 - A minimally invasive device for stomach-reduction surgery consisting of a stapling tool that can be passed down the throat into the stomach
• Company 1163 - Kidney stone management device and urethral dilating introducer
• Company 1164 - Ventricular elastic support therapy for heart failure
• Company 1165 - Plastic medical devices for gynecological exams and surgeries
• Company 1166 - Inferior vena cava filters
• Company 1167 - Neuromodulation system for both traumatic brain injury (TBI) and stroke
• Company 1168 - Minimally traumatic, bone- and cartilage-preserving knee implants and instrumentation
• Company 1169 - Radio-frequency (RF)-based tissue sealing and cutting instruments with a long jaw sealing length and high quality seal to greatly reduce procedure time and surgeon fatigue
• Company 1170 - Fast, accurate, and easy-to-use in vitro molecular diagnostic products that rapidly identify infectious pathogens
• Company 1171 - Unique spinal implant designed to promote rapid fusion
• Company 1172 - Devices for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
• Company 1173 - Unique transcranial magnetic stimulation system that allows direct non-invasive activation of deep brain structures
• Company 1174 - Dynamic "shape memory" platform to optimize mitral/tricuspid valve repair
• Company 1175 - Single molecule DNA analysis system, with no requirement for prior sequence information/PCR/cloning/probes
• Company 1176 - Biomaterials-based medical devices focusing on cardiovascular, metabolic, inflammatory, and fibrotic diseases
• Company 1177 - Transdermal/wound dressing/mucosal drug delivery
• Company 1178 - A unique solution similar to ring annuloplasty/edge-to-edge repair, all in one modality, for mitral valve repair
• Company 1179 - Minimally invasive devices that improve oxygenation for patients with COPD
• Company 1180 - Hands-free internal retractor/internally-anchored laparoscope camera cleaner
• Company 1181 - Particle technologies for the treatment/prevention of chronic respiratory disorders
• Company 1182 - Minimally invasive, single-procedure approach for the repair of cartilage damage/osteoarthritis
• Company 1183 - Biodegradable synthetic hydrogels for general and specialty surgery use
• Company 1184 - Silk-based biomaterial platforms for tissue rejuvenation/connective tissue repair
• Company 1185 - Ankle replacement implant for patients with chronic pain/arthritis
• Company 1186 - Biomarker assays for the early detection of cancer
• Company 1187 - 1-Painless intradermal drug delivery, 2-GERD diagnostic device, 3-Non-invasive continuous glucose monitoring
• Company 1188 - Detection products for viral/bacterial infections, genetic diseases, mutations, cancers, etc.
• Company 1189 - Video integration and equipment management system to enhance the MIS market
• Company 1190 - Multi-pixel x-ray source for enhanced system performance/new capabilities
• Company 1191 - Combination ultrasound/electrical stimulation device for skin rejuvenation
• Company 1192 - High-durability tissue heart valves for transcatheter and surgical implantation with percutaneously-exchangeable leaflets for lifetime service without anti-coagulation therapy
• Company 1193 - Advanced suturing technology for minimally invasive/NOTES/bariatric/cardiac/other surgical specialties
• Company 1194 - A minimally invasive electromagnetic navigation system for early detection of lung cancer
• Company 1195 - Patient-centric data system and analysis tools for translational medicine and research
• Company 1196 - Hand-held device to monitor post-operative/trauma patients for early warning signs of sepsis or infection in the bloodstream
• Company 1197 - Spinal cage with dynamic stabilization/MIS placement (3mm access) and easily revisable
• Company 1198 - Fully modular total hip replacement systems to reduce wear/add longevity
• Company 1199 - A "plug & play" system for treating non-invasive, curative, and palliative cancers and precursors
• Company 1200 - Products for the early detection of lung and oral cancers
• Company 1201 - System that performs a non-invasive, 30-second test to identify the risk of heart disease
• Company 1202 - Non-molecular bacterial screening, identification, and antibiotic susceptibility testing
• Company 1203 - Optical coherence tomography for evaluation of human tissue microstructure with real-time depth visualization
• Company 1204 - Wireless electronic skin patch sensors for the real-time measurement/monitoring/diagnosis/clinical management of cardiac arrhythmias
• Company 1205 - Non-fusion spinal solutions that control segmental motion/maintain the neutral zone simultaneously
• Company 1206 - Optical cell sorters used in stem cell/cell therapy treatments for cancer, autoimmune disease, and regenerative medicine applications
• Company 1207 - BQT®, a non-invasive point-of-care diagnostic test for osteoporosis and bone fracture risk
• Company 1208 - Low-mass PFO closure system capable of repairing the defect from within the tunnel
• Company 1209 - Third-generation biodegradable annuloplasty rings
• Company 1210 - Easy-to-use, instrument-free, disposable molecular diagnostic tests
• Company 1211 - 1-Bone cement to replace PMMA-based materials, 2-A liquid hydrogel wound dressing able to cure rapidly and in situ
• Company 1212 - Monitoring system to replace the manual assessment of labor progress with real-time/continuous information
• Company 1213 - Delivery of proteins and peptide drugs without burst, with near-zero order release, and with high bioavailability
• Company 1214 - Contrast agents/molecular imaging for detection using a modified porous Silicon (mpSi™) platform
• Company 1215 - Aerolase cosmetic lasers have user-validated superiority on key attributes: efficacy and safety, particularly on hard to treat darker complexions; unique multi-purpose function and portability; yet industry-low cost
• Company 1216 - SutureCross™: Knotless Anatomic Fixation System for double row arthroscopic rotator cuff repair
• Company 1217 - Biodegradable surgical adhesive for seroma reduction in plastic surgery
• Company 1218 - Miniature blood pump, designed to be placed superficially like a pacemaker, for the long-term treatment of chronic heart failure (CHF)
• Company 1219 - Devices that use bio-electric stimulation therapy (bio-current) to treat hard-to-heal wounds
• Company 1220 - Minimally invasive catheter-based ablation technologies to treat atrial fibrillation and other cardiac arrhythmias
• Company 1221 - Transvaginal, ultrasound image-guided HIFU device, capable of real-time guidance and monitoring of therapy
• Company 1222 - A portable breath collection apparatus (BCA) which can collect breath samples virtually anywhere, for highly sensitive laboratory analysis
• Company 1223 - Automatic tools to support image visualization, lesion detection and quantification, temporal evolution assessment, and automatic reporting in chest and abdominal CT scans
• Company 1224 - RNA-based therapeutics
• Company 1225 - Wireless seizure alarm systems for people with epilepsy
• Company 1226 - Arm training device to restore arm movement in stroke patients who have experienced arm paralysis
• Company 1227 - Ophthalmic formulation of mitomycin-C in a single-use kit, for use in the surgical treatment of glaucoma
• Company 1228 - Products to diagnose the risk for heart attacks by means of assessing endothelial function
• Company 1229 - Minimally invasive medical devices for patients who are at risk for or have suffered a stroke
• Company 1230 - AOKit™-bio: an adaptive optics kit for biologists which enhances microscopic imaging
• Company 1231 - Neowater®, a water-based nanotechnology which has physical properties that mimic intracellular water
• Company 1232 - Metabolomic profiling of biomarkers for the diagnosis of early forms of dementia and neurodegenerative diseases
• Company 1233 - A portable oxygen delivery and ventilation system
• Company 1234 - Interventional bronchoscopy devices for lung diseases
• Company 1235 - Advanced endotracheal tube for intubation, fitted with advanced fiberoptic visualization technology
• Company 1236 - Modular hip stem technology and total knee replacement systems
• Company 1237 - First viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure (CHF)
• Company 1238 - Fusion and non-fusion spinal implants
• Company 1239 - A device that seals blood vessels after hemodialysis as an alternative to central venous catheters for kidney-dialysis patients
• Company 1240 - Non-invasive ultrasound body contouring
• Company 1241 - Non-invasive, painless, Navigated Brain Stimulation (NBS) for brain diagnostics and therapy
• Company 1242 - Noninvasive breast cancer risk assessment device
• Company 1243 - Low cost, easy-to-use, credit-card-sized devices which will allow on-the-spot quantitative diagnosis
• Company 1244 - Telemedicine paired with state-of-the-art ophthalmologic imaging
• Company 1245 - Devices for treating cardiovascular disease
• Company 1246 - Precision surgical systems for computer-assisted 3D planning, surgical navigation, and surgeon-controlled robotic surgery
• Company 1247 - Female sterilization technology
• Company 1248 - Electromedical/electrotherapeutic equipment
• Company 1249 - Products for the minimally invasive repair of long bone fractures
• Company 1250 - Molecular diagnostic products for laboratories that are intended to enhance medical care by providing early diagnostic information rapidly
• Company 1251 - New pulmonary drug delivery system
• Company 1252 - Next-generation laser therapy
• Company 1253 - Devices for the in-office polypectomy/myomectomy market
• Company 1254 - Low-cost, fast, and accurate molecular diagnostic products
• Company 1255 - EXPANSE Vertebral Body Replacement Device for use in the thoracolumbar spine
• Company 1256 - An oncology visualization system that integrates advanced graphics processing capabilities with proprietary software algorithms to register multiple CT image sets in real-time
• Company 1257 - Minimally invasive, single-use, disposable devices that enable incisionless, transoral procedures for the treatment of a number of upper gastrointestinal problems, including gastrointestinal reflux disease (GERD) and failed bariatric surgery
• Company 1258 - Mobile phone-based data collection for chronic disease management
• Company 1259 - Advanced gene expression and DNA quantification products and services
• Company 1260 - Optical backscatter technology to improve the way cancer is detected and diagnosed
• Company 1261 - Laser, light-based, and radiofrequency devices for aesthetic and medical applications
• Company 1262 - Diagnostic methods using microarray gene expression profiling to determine specific properties of tumors
• Company 1263 - Catheter-based devices which rapidly provide quantitative data to the physician about vessel and stent size, suitable for peripheral and cardiac applications
• Company 1264 - Advanced wheelchair technologies
• Company 1265 - Human bionic devices that can instantaneously interact with the human body to replace or restore biomechanical or physiological functions
• Company 1266 - Cell-based epicardial patch designed to promote blood vessel growth in ischemic cardiac tissue
• Company 1267 - Methods for treating human tissue based on volumetric bipolar radio frequency ablation (RFA), and surface ablation of tissue
• Company 1268 - Infusing normothermic fluids from 10mL/hour-1200mL/minute with 30-second setup through a disposable cassette
• Company 1269 - Technology using opto-acoustics for functional imaging/cancer diagnosis
• Company 1270 - High-intensity focused ultrasound in a catheter to treat atrial fibrillation
• Company 1271 - 1-Alternative to instrument-based viscosity testing; 2-A disposable blood to plasma device for use in micro-fluidic assays; 3-A home-use test for clotting time
• Company 1272 - Portable, easy-to-use consumer device that allows for easy, safe and green disposal of used insulin syringes, lancets and pen needles by vaporizing the sharp
• Company 1273 - Site-specific catheter-guided system to deliver drugs and biologics directly to the adventitia
• Company 1274 - Device based therapy targeting ischemic brain stroke and chronic heart failure
• Company 1275 - Integrated wireless monitoring
• Company 1276 - Non-invasive robotic radiosurgery system for cardiac ablation
• Company 1277 - Ceramic components for spine, orthopaedic, and other implant needs
• Company 1278 - Target-specific recombinant human protein focused on spinal fusion surgery
• Company 1279 - Patient controlled analgesia device for pain management
• Company 1280 - Less invasive orthopaedic implant solutions employing advanced pliable structured materials and innovative designs
• Company 1281 - Dual function, automatic, handheld sinus irrigator and aspirator for OTC consumer use
• Company 1282 - Computer-integrated robotic instrumentation/navigation tools for orthopedic surgery
• Company 1283 - Next-generation disposable colonoscope incorporating diagnostic/therapeutic capabilities allowing for a potentially sedation-less treatment
• Company 1284 - Total hip replacement system that addresses resistance to wear and resistance to dislocation with ceramic and double mobility
• Company 1285 - Percutaneous mitral valve replacement system for treatment of mitral regurgitation
• Company 1286 - Non-invasive continuous glucose monitoring device, for patients with diabetes, based on a multi-sensor platform
• Company 1287 - Growth factor and biomaterial addressing the needs of spinal fusion, osteochondral defects, osteoarthritis, dental medicine, and other indications
• Company 1288 - Open-sky, cryogen-free, superconductive MRI scanner that uses a U-shaped magnet with no barriers in between the patient and the environment for orthopaedic, general purpose, and interventional applications
• Company 1289 - Minimally invasive retractors for pelvic surgery to optimize pneumoperitoneum pressure and patient position (OP5)
• Company 1290 - Handheld device which measures the amount of calories a person requires to maintain body weight
• Company 1291 - Intelligent nasal drug delivery devices for topical, systemic and nose-to-brain applications
• Company 1292 - Developing a fully implantable extra-aortic counterpulsation device designed to provide long-term, cost-effective treatment and significantly improve quality of life for heart failure patients
• Company 1293 - An absolutely non-invasive, radiation- and side-effect free electro physiological high speed cardiac diagnostic system to identify upcoming heart attacks and sudden cardiac deaths
• Company 1294 - DART is utilizing an interstitial radiation source that by nuclear decay recoil mechanism emits high-energy alpha particles widely dispersed by diffusion and by convection in the tumor mass
• Company 1295 - Producer of surgical devices including a self-attaching hernia patch, anti-clog surgical drain, and cavity implosion device
• Company 1296 - Non-surgical serum based cure, proven effective for PAD, Diabetic and Cardiovascular disorders
• Company 1297 - Portable and networked medical devices such as handheld ultrasounds
• Company 1298 - Single-use rigid endoscopes, with superior image quality, at a reduced per-use cost
• Company 1299 - Providing private and hospital-based OB/GYNs, Perinatologists, and Radiologists with integrated reporting and image management systems
• Company 1300 - Minimally invasive ophthalmic device therapy for Dry Macular Degeneration and other blindness causing diseases
• Company 1301 - Minimally invasive surgical technology that uses ionizing radiation to treat wet age-related macular degeneration (AMD)
• Company 1302 - An automated blood glucose monitor for the intensive care unit using near infra-red spectroscopy
• Company 1303 - Human Globin, a biopolymer to replace animal collagens in dermal fillers and create biomaterials for tissue repair
• Company 1304 - Indigo Orb, Inc is a technology leader in "Automatic Detection of Epidural Cavity"
• Company 1305 - Developing and marketing EEG systems, tools and services for Neurologists, Neurosurgeons, and Neuroscience Researchers
• Company 1306 - Orthopedic products, specifically for upper and lower extremity small bone applications
• Company 1307 - Lumbar system for dynamic stabilization without fusion, artificial discs, and minimally invasive surgery systems
• Company 1308 - Reintroducing CHYMOPAPAIN, the only proven minimally-invasive therapy for herniated discs; it allows nuclear regeneration.
• Company 1309 - 1-Lumbar cage with integrated fixation screws, 2-Pedicle screw product line, 3-Access systems and implants for use in minimally invasive surgery (MIS)
• Company 1310 - Surgical adhesives that serve to augment or replace sutures and staples/tacks
• Company 1311 - Revisable cervical and lumbar total disc replacement that can be converted to fusion
• Company 1312 - Motion preservative artificial disc
• Company 1313 - Two clinically proven lumbar, motion-preservation spinal implants that offer surgeons: 1-a lumbar joint replacement that has provided superior treatment over fusion and disc replacement, for patients with degenerative lumbar joint disease and 2-a posterior dynamic stabilization system used to restabilize the spine after surgery for spinal stenosis, as an alternative to lumbar fusion
• Company 1314 - Building on an exclusive intellectual property platform for both fusion and non-fusion products
• Company 1315 - Tumor necrosis factor alpha (TNF-a) inhibitor therapy for treatment of chronic persistent radiculopathy (including sciatica) related to disc herniation.
• Company 1316 - Spinal implants, cervical, thoracolumbar, interbody, bone substitutes, motion preservation
• Company 1317 - Biocellulose technology that eliminates the risks/complications/limitations inherent in animal, human, and synthetic biomaterials
• Company 1318 - Wireless patient vital signs monitoring
• Company 1319 - Disease management system for early detection of heart failure using a noninvasive cardiovascular-sleep prognostic marker
• Company 1320 - 1-Soft tissue attachment nanotechnology, 2-Bioactive/biocompatible/osteoconductive synthetic bone filler, 3-Biodegradable fiberglass fiber & composites
• Company 1321 - Noninvasive blood glucose monitor that will measure glucose in sweat in a disposable dermal patch
• Company 1322 - Affordable thermal systems that are portable, easy-to-use, and comfortable to wear
• Company 1323 - High Intensity Focused Ultrasound for incisionless male surgical sterilization
• Company 1324 - Ambulatory infusion pumps and disposables that require no programming and use pre-filled solution containers
• Company 1325 - ViaDerm - home use transdermal drug delivery system creating microscopic passageways in the top skin layer
• Company 1326 - Tools for enabling adult stem cell based regenerative medicine
• Company 1327 - Lectin-based cell adhesion technology which enables stents that traffic cells in the bloodstream
• Company 1328 - Programmable lab-on-a-chip platform for applications ranging from drug discovery to consumer diagnostics
• Company 1329 - Technology that enables real-time tracking of the position and orientation of any interventional tool - biopsy device, catheter, endoscope, ablation probe, marker dispenser, etc.
• Company 1330 - Blood tests for the early detection of breast cancer, ovarian cancer, lung cancer, Alzheimer's, and other serious diseases where significant unmet clinical needs exist
• Company 1331 - Spinal implants utilizing elastomeric polymers for non-fusion treatment of disc degeneration
• Company 1332 - ECG software for assessing acute ischemia and cardiac safety surrogates in clinical trials
• Company 1333 - Resorbable pegylated hydrogel for surgical wound sealing/adhesion prevention/sustained and targeted drug delivery
• Company 1334 - The Sensation
• Company 1335 - Robot-assisted stroke therapy devices
• Company 1336 - Endothelial management - less trauma combined with new agents for improved healing in vascular interventions
• Company 1337 - Digital Pulse Analyzer - provides early detection of arterial wall stiffness and biological age of arteries
• Company 1338 - Diagnostic platform with a test for measuring unbound Bilirubin for the management of newborn jaundice
• Company 1339 - Percutaneous light activation reduces intra-abdominal fat, returning Type 2 diabetic patients towards normoglycemia
• Company 1340 - 1-Cartilage implant for the knee, 2-Injectable cell therapy for the spinal disc/nucleus, 3-Bone graft extender to treat spinal deformities
• Company 1341 - Protein free induction of endochondral ossification, no human origin, not contagious, no soft tissue ossification
• Company 1342 - 1-Instant-on/instant-off proximal occlusion funnel catheter, 2-Scoring balloon with drug delivery capability
• Company 1343 - An internal adhesive biotechnology designed for strength, biocompatibility, and ease-of-use with applications in cardiovascular surgery
• Company 1344 - Technology that prepares the spinal disc for a nucleus replacement/minimally invasive fusion device
• Company 1345 - Tissue repair devices exploiting shear force transfer and large-interface substrates for adherent new tissue formation
• Company 1346 - Advanced skin biopsy and wound healing solutions to dermatology, cosmetic, primary care, and oncology clinicians
• Company 1347 - Advanced optical systems/services that are changing the way doctors evaluate and treat the eye
• Company 1348 - Non-invasive cardiac output monitoring to assess stroke volume, contractility, cardiac output, cardiac index, and thoracic fluid content
• Company 1349 - 1-Cardiovascular-directed growth factor therapeutics; 2-Endovascular catheter-based system to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events
• Company 1350 - A drug delivery platform that approaches the endovascular bifurcation challenge from a completely different angle
• Company 1351 - A bioactive ceramic that delivers better/faster spine fusion and bone repair
• Company 1352 - Percutaneously delivered implantable system to treat mitral valve regurgitation and improve congestive heart failure
• Company 1353 - Electro-grafting coating technology for implantable biomedical applications; used for the fast healing post drug-eluting-stent (DES) implantation (avoiding late stage thrombosis)
• Company 1354 - Noninvasive medical device for the treatment and prevention of obesity using controlled hypoxia
• Company 1355 - An implantable ophthalmic device to treat vision correction associated with Age-Related Macular Degeneration (AMD)
• Company 1356 - Accommodating and multifocal phakic IOLs, CE-approved for $ billion refractive IOL market
• Company 1357 - Biocompatible polymer implant to prevent or reverse the progression of chronic heart failure and mitral valve regurgitation
• Company 1358 - Noninvasive device used in the differential diagnosis of disc or facet mediated low back pain
• Company 1359 - Surgical stapling devices for open and laparoscopic procedures developed for the growing China market
• Company 1360 - The first-and-only, fully self-contained, low-cost, and market-proven disposable iontophoretic patch - topical drug delivery platform for enhanced penetration and efficacy
• Company 1361 - IBraces - 100% customized, invisible orthodontic braces designed for efficient, effective treatment of teens and adults
• Company 1362 - Flash Ultrasound
• Company 1363 - Free-floating optical probe with multiple LD scanning and magnetic stabilization for noninvasive blood glucose monitoring
• Company 1364 - Repositionable/removable percutaneous heart valve, precision controlled delivery device, and calcified valve encapsulation system
• Company 1365 - Next-generation estrogen-based drug-eluting coronary stent and an orthopedics/sports injury pain management device
• Company 1366 - Heart pump that achieves superior flow and pressure performance, mimicking the physiological performance of the human heart, and reducing post-surgery kidney failure, mortality, and complications cost by 50%
• Company 1367 - Porcine-derived tissue devices for ligament, cartilage, bone, and soft tissue replacement and augmentation
• Company 1368 - MIS platform technologies for creating cavities in tissue and partially molding an orthopedic implant in situ
• Company 1369 - Orbital atherectomy for the treatment of peripheral vascular disease
• Company 1370 - Functional brain imaging centers that identify Alzheimer's, brain injury, stroke, ADHD, bipolar, depression, anxiety, OCD
• Company 1371 - A protein therapeutic biotreatment that regresses solid tumors and protects against relapses
• Company 1372 - Analyze, search, store, mine, share and unlock the power of digital tissue images
• Company 1373 - Smart devices to harness human physiology for health care, industrial safety, and law enforcement applications
• Company 1374 - Naturally-derived/non-crosslinked/collagen-based extracellular matrix to repair/remodel damaged tissues
• Company 1375 - Facet fixation system that is a less-invasive/faster alternative to pedicle screw fixation
• Company 1376 - Catheter-based technology for orthopedic trauma indications providing site-specific tissue drainage and drug delivery
• Company 1377 - Shielded reciprocating tissue sculpturing instrument, able to navigate into neural foramen to relieve nerve compression
• Company 1378 - 1-LIFEBACK® Spine Programs for non-operative and post-operative spine patients and 2-the LTX 3000® Rehabilitation System
• Company 1379 - Stable and extractable self locking intramedullary nails and proximal femoral fixation
• Company 1380 - Emperor Mobile Spinal Disc, P.E.E.K Cages, Pedicle Screw System, and Saturn Hip Resurfacing
• Company 1381 - Rapid table-mounted retraction/surgical site access for MIS placement of hip/knee/shoulder/spine implants
• Company 1382 - Lumbar dynamic stabilization with MIS compatibility and pedicle screws
• Company 1383 - Real-time image-guidance technology with an FDA-accepted accuracy claim of +/-1mm at 1 meter
• Company 1384 - Noninvasive, ambulatory, portable, 3-D traction technology providing an effective and unique therapy for spinal disorders
• Company 1385 - Fusion technology platforms and second-generation artificial discs for the lumbar and cervical spine
• Company 1386 - A biological and mechanical solution to annular repair and spine fusion
• Company 1387 - Low-profile implants/less invasive surgical instruments to treat spinal disorders utilizing fusion and non-fusion technologies
• Company 1388 - A CE-marked resorbable plating system for cervical fusions allowing for load sharing
• Company 1389 - Biomaterials-based product that augments or replaces the diseased nucleus pulposus of the spinal disc
• Company 1390 - Nitric oxide-based therapies to accelerate healing of tendon, bone, and other musculoskeletal tissue
• Company 1391 - Drug product for the treatment of acute spinal cord injury, cancer, macular degeneration, and glaucoma
• Company 1392 - Synthetic bone that duplicates the microstructure, composition, and performance of human bone
• Company 1393 - Implanted oscillating field stimulation device which regenerates acute and sub-acute damaged spinal cord nerve tissue
• Company 1394 - PuraMatrix injectable synthetic nanofibrous hydrogels for bone, cartilage and soft tissue regeneration, and drug delivery
• Company 1395 - Noninvasive device providing substitute vestibular sensory information through the tongue for treatment of balance disorders
• Company 1396 - Naturally occurring neuropeptide to treat ischemia associated with myocardial infarction, heart failure, and angina
• Company 1397 - Miniature/patient-controllable/valved catheter to improve quality of life/decrease urinary tract infections in patients suffering urinary retention
• Company 1398 - Phase-shifting technology for Contrast Ultrasound imaging
• Company 1399 - Medical devices, utilizing robust tyrosine-based resorbable polymer systems/pharmaceuticals in surgical barriers/cardiac rhythm management
• Company 1400 - Laparoscopic surgical access technology based on a No-Seal platform
• Company 1401 - Theramers
• Company 1402 - Respiratory diagnostics for noninvasive assessment of airway acidification in Asthma, COPD, and GERD
• Company 1403 - A "preventative" vaccine for HIV-AIDs
• Company 1404 - Post-proteomics multiplexed MS-based diagnostics/theranostics linked to drug development and personalized medicine
• Company 1405 - Image-guided therapy for metastatic liver disease
• Company 1406 - Biomaterial that regulates resorbability and enhances bone regeneration
• Company 1407 - Drug/device products for post-operative pain and orthopedic drug delivery indications using syntinate synthetic absorbables
• Company 1408 - Ultrasonic medical devices for minimally invasive therapeutic procedures for treatment of cancer/other healthcare purposes
• Company 1409 - Multi-channel implantable microelectrodes for deep brain stimulation and recording, enabling enhanced neuromodulation therapies
• Company 1410 - Aesthetic treatment device using collimated high-energy light and laser, delivered simultaneously by fiber delivery system
• Company 1411 - A remotely controlled, wireless-powered implantable 230-channel nerve stimulator built on a 15
• Company 1412 - Real-time, noninvasive monitoring of blood loss, anemia, and other vital blood measurements
• Company 1413 - Small/portable/handheld device for diagnosing brain hematomas
• Company 1414 - Fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify lipid rich plaques in the coronary arteries
• Company 1415 - Laparoscopic surgeons maintain direct control of the laparoscope movement/placement with GMP's Laparocision
• Company 1416 - Rapid testing systems led by the Growth Direct
• Company 1417 - World's smallest leg compression device for the prevention of deep vein thrombosis (DVT) in surgical patients, as a safe and effective alternative to Lovenox, for a significantly reduced price
• Company 1418 - Ultraviolet light technologies for the inactivation of RNA viruses in/out of the body
• Company 1419 - Minimally invasive percutaneous neuromodulation pain therapy
• Company 1420 - The Axya Shoulder Fixation System generates ultrasonic energy for knotless suture welding in shoulder surgery
• Company 1421 - Gene-based products for the diagnosis and treatment of spinal disorders
• Company 1422 - A platform aerosol drug delivery nebulizer device for multiple- and single-use applications with disposables
• Company 1423 - Non-invasive continuous measurement of tissue oxygenation for various intraoperative and post-operative applications
• Company 1424 - Vascular stents and grafts with increased patency by improved flow dynamics, reducing stenosis and restenosis
• Company 1425 - 1-Next-generation liquid embolic for treating cerebral aneurysms and arteriovenous malformations (AVMs); 2-Two wound management products that will be out-licensed
• Company 1426 - SurfLink
• Company 1427 - Bifurcated coronary stent
• Company 1428 - Monitoring products based on microsensor technology allowing minimally invasive, real-time measurement of clinical chemistry parameters and therapeutic drug concentrations
• Company 1429 - Noninvasive, outpatient bariatric device for overweight/obesity
• Company 1430 - A suite of tools for automated CT Angiography (CTA) diagnostics for Coronary Artery Disease
• Company 1431 - Magnetically actuated telescopic intramedullary (IM) nail activated by an induced low power directional magnetic field
• Company 1432 - Transdermal delivery system of levodopa (L-DOPA) for the treatment of Parkinson's Disease
• Company 1433 - Immediate, active, device-less, and painless topical drug delivery, of small/macromolecules, for local/systemic indications
• Company 1434 - Endotracheal tube with video, self-locking orthopedic implants, structured TPN lipids, cell therapy for cancer, etc.
• Company 1435 - Products that digitize manual breast examination tissue elastic properties into objective computerized visual maps/reports
• Company 1436 - Technology for the manipulation of adult stem cells to repopulate chronically diseased liver tissue
• Company 1437 - Non-invasive airway clearance in ICU patients to prevent ventilator associated pneumonia
• Company 1438 - Unique add on and removable needle safety product that fits to standard glass/plastic syringes
• Company 1439 - Medical devices utilizing radiofrequency and microwave energy which are cost-effective and clinically relevant
• Company 1440 - Non-invasive screening of Peripheral Arterial Disease (PAD), combining postural/infrared blood volume testing
• Company 1441 - Tissue fixation implants, injectable bone grafting biomaterials, and tissue scaffolds with drug releasing properties
• Company 1442 - Miniature implantable, continuous blood glucose sensor for diabetics, incorporating noninvasive wireless monitoring
• Company 1443 - Coronary guidewire, to provide real-time ultrasonic measurement of coronary arteries to determine stent size and apposition without exchange of catheters
• Company 1444 - Bioabsorbable, bioactive, and drug-releasing medical device products for various fields of surgery
• Company 1445 - 1- Interventional single-use cardiac support device and drug delivery platform, 2- Implants for use in/with magnetic resonance imaging (MRI) systems
• Company 1446 - Endoscopically-placed devices to prevent GERD, obesity, and irritable bowel syndrome (IBS)
• Company 1447 - Cellular implants for orthopedic, trauma, and spinal applications based on a biological form stable matrix
• Company 1448 - SmartStep
• Company 1449 - Dynamic optimization of pacing intervals according to hemodynamic sensors for CRT devices
• Company 1450 - Neuro-monitoring systems for brain protection and stroke acute care in stroke units, cardiovascular ORs, during stenting, and in the ICU
• Company 1451 - Medical devices that enable diabetes disease management and the prevention of lower extremity amputations
• Company 1452 - Customized miniature disposable stereoscopic cameras that provide 3D vision, measurements, and image fusion in real-time
• Company 1453 - Infusion catheter for treatment of tumors which are unresponsive to systemic chemotherapy by the local delivery of drugs and other agents
• Company 1454 - Non-invasive imaging tool designed to provide automated, 3-D ultrasound images of the breast
• Company 1455 - RFID hardware and software platform for test tubes/ apheresis device for blood component separation
• Company 1456 - Saliva-based consumer diagnostic systems, which enable the development of personalized therapeutics
• Company 1457 - Disposable, noninvasive, pump-less, and valve-less automatic blood pressure monitor "on-a-chip"
• Company 1458 - Noninvasive neural vision enhancement
• Company 1459 - Nanotechnologies for use in orthopedic implants, dental implants, and stents
• Company 1460 - Specialty and standard electrophysiology catheters that have superior performance, advantageous features, and are affordable
• Company 1461 - Dedicated angioplasty and stent systems for the treatment of arterial bifurcations
• Company 1462 - System to ablate cardiac tissue as a means to potentially treat atrial fibrillation
• Company 1463 - Point-of-care IVD platform that provides rapid, accurate, automated laboratory testing using low cost, disposable biochips
• Company 1464 - Interventional MRI technology for cardiovascular imaging including detection/treatment of vulnerable plaque
• Company 1465 - System analyzes a patient's susceptibility to cardiac arrest and consequent need for implantable defibrillator
• Company 1466 - Patient recovery system for cosmetic and reconstructive surgery
• Company 1467 - Microscope slide scanners and information management software that enable the digitization of pathology
• Company 1468 - SutureLock - a versatile suture-securing knot-replacement device for endoscopic wound approximation
• Company 1469 - Multi-Sensing Wireless Catheter platform attached along the GI-Uro tract detecting GERD, incontinence, and other abnormalities
• Company 1470 - Noninvasive medical device providing low-risk hypoxic treatment that induces appetite suppression and weight loss
• Company 1471 - Minimally invasive telemetric and continuous measurement of left atrial blood pressure at heart failure
• Company 1472 - Catheter-based photoreactive treatment system for endovascular intervention in coronary and peripheral atherosclerotic disease
• Company 1473 - Transcatheter mitral valve repair - will move mitral valve annuloplasty from a major open heart surgical procedure to a minimally invasive cardiac catheterization procedure
• Company 1474 - A platelet reactivity test to measure the effect of anti-platelet drugs, particularly aspirin and Plavix
• Company 1475 - OmniWave(R) catheter-based technology that delivers transverse ultrasonic energy to targeted thrombus in a diseased blood vessel, without damaging the surrounding vessel walls
• Company 1476 - A portable laseroptical system for noninvasive differentiation between ischemic stroke and spontaneous intracerebral hemorrhages
• Company 1477 - Alginate-based embolic material designed to fill blood vessel defects thereby displacing blood pressure effects and preventing vessel rupture
• Company 1478 - A wearable continuous ultrafiltration device that removes fluid overload in patients with Congestive Heart Failure
• Company 1479 - Minimally-invasive cardiac implantable devices for treating mitral valve regurgitation without atriotomy or cardiopulmonary bypass
• Company 1480 - Surgical and percutaneous cardiac valve repair
• Company 1481 - Percutaneous mitral valve repair simulating precision of surgical annuloplasty
• Company 1482 - Pressure and flow sensing systems for vascular and other applications
• Company 1483 - Advanced ECG-heart sound analysis to enable superior diagnosis/monitoring of CHF/ACS patients
• Company 1484 - Minimally invasive interventional radiology/vascular surgery devices
• Company 1485 - PeriVasc
• Company 1486 - Perfusion monitoring for preventing septic shock, the greatest hospital mortality
• Company 1487 - A noninvasive test for endothelial dysfunction using digital (fingertip) thermal monitoring
• Company 1488 - Stentless aortic valve prosthesis to be delivered via catheter
• Company 1489 - Catheter-based therapy which increases cerebral perfusion for the treatment of ischemic stroke and vasospasm
• Company 1490 - Catheter-based devices to reconstruct the ventricle and downsize the heart volume
• Company 1491 - Non-invasive device using muscular counter pulsation (MCP) technology for the treatment of acute and chronic heart failure (CHF) in a clinical, ambulatory, or at-home setting
• Company 1492 - 1-Bio-therapeutic designed from autologous stem cells and committed to a cardiac lineage before implantation, 2-Corresponding catheter for accurate transmyocardial injection
• Company 1493 - Minimally invasive device-based technologies targeting the treatment of hemodynamic instability and perfusion
• Company 1494 - Peptide-based therapeutic to enhance stent/graft patency
• Company 1495 - Biomimetic coronary stent coating that prevents restenosis/reduces the need for extended courses of dual antiplatelet therapy
• Company 1496 - Disposables for drawing blood -- percutaneous or from a catheter -- neonates to geriatrics
• Company 1497 - Electrode sensor array, with integrated lead wires, simple, accurate and repeatable ECGs
• Company 1498 - In vivo plasmapheresis and ultrafiltration to remove excess fluid from CHF patients in clinical trials
• Company 1499 - Noninvasive therapeutic ultrasound to enhance perfusion for treatment of acute myocardial infarction
• Company 1500 - Affordable handheld metabolic monitor (indirect calorimeter) with both medical and consumer weight management applications
• Company 1501 - Unique microsphere-based technology for chronic/acute wounds
• Company 1502 - Technologies that utilize flexible cross linking and sterilization processes which stabilize and sterilize biological tissue for use in orthopedic, wound, oral/dental, spine and neurological, breast, abdominal and thoracic applications
• Company 1503 - Devices for mechanically induced bone growth, together with a "smart device" system for risk management
• Company 1504 - Nitric oxide releasing surface treatments for enhanced biocompatibility in medical devices
• Company 1505 - Automated implantable pump systems for moving fluids around inside the body
• Company 1506 - Minimally invasive surgical access system used in laparoscopic surgery
• Company 1507 - Long-term, miniature drug delivery implant with physician- controllable, zero-order release characteristics
• Company 1508 - 1-Single-use, patented, disposable, hemorrhoid banding system; 2-Two-tier colon cancer diagnostic screen, Fecal Occult Blood Testing (FOBT)
• Company 1509 - Interventional catheter-based system precisely measures stent and arterial size and cardiovascular repair tissue patch products
• Company 1510 - Device for the treatment of mitral regurgitation and heart failure without requiring open heart surgery
• Company 1511 - Light-based therapy for eradication of ulcer-causing Helicobacter pylori
• Company 1512 - Non-invasive medical radar imaging for cardiopulmonary ambulatory monitoring and diagnosis
• Company 1513 - Enteric Dialysis with Kibow Biotics - a food-grade microbial Gel cap formulation towards kidney failure applications
• Company 1514 - IYIA has developed a proprietary, clinically effective device, O2Misly, for treating slow healing foot wounds, primarily diabetic foot ulcers
• Company 1515 - Genetic and personal history based testing to predict age-specific risk of breast cancer diagnosis
• Company 1516 - Controlled fluid delivery system for every medical application without batteries or power cords
• Company 1517 - Non-contact intelligent medical vigilance for the hospital
• Company 1518 - Capture and analysis of heart sounds leading to rapid and accurate diagnosis of cardiac pathologies
• Company 1519 - Blood test that screens/diagnoses cervical cancer without need of a cervical exam/pap smear
• Company 1520 - Implantable Left Ventricular Assist Device (LVAD) for heart failure
• Company 1521 - Bioabsorbable drug eluting stents and stent coatings for treatment of vulnerable plaque and coronary stenosis
• Company 1522 - Electronic pill for oral delivery of low bioavailability drugs
• Company 1523 - Microsyringe delivery of cells, genes, and drugs to the vasculature/deep tissues of the body
• Company 1524 - Percutaneous noninvasive heart valve replacement
• Company 1525 - Molecular FingerPrinting process for early-stage diagnosis of cancer, enabling point-of-care therapeutics based on gene regulation
• Company 1526 - Percutaneous access management system to provide early ambulation/eliminate major complications, leaving nothing behind in patient
• Company 1527 - Totally implantable LVAD that does not interface with circulating blood
• Company 1528 - Blood test for breast cancer measuring 5 protein biomarkers using super-sensitive ELISA with 95% accuracy
• Company 1529 - Ablation technology that delivers radiofrequency energy endoscopically, to eliminate Barrett's esophagus and prevent esophageal cancer
• Company 1530 - A device for the left atrial appendage for stroke prevention in patients with atrial fibrillation
• Company 1531 - Noninvasive monitor to measure exhaled nitric oxide for the management of asthma
• Company 1532 - Microplate-based electronic biosensor system for label-free, real-time cell based assays
• Company 1533 - Interactive intraoperative CT scanning technology for image-guided interventions
• Company 1534 - High Intensity Focused Ultrasound for minimally invasive thermal treatment of disc herniation without disc penetration
• Company 1535 - Percutaneous systems to treat lower back pain
• Company 1536 - Least invasive approach for the delivery of lumbar fusion and motion preservation therapies
• Company 1537 - Telemeterized natural motion elastomer disc
• Company 1538 - Interspinous process implant to treat Lumbar Spinal Stenosis (LSS)
• Company 1539 - Clinical expertise, facility development, new technology, and business services including marketing and contracting
• Company 1540 - Advance and commercialize less invasive spinal deformity surgical treatment without fusion
• Company 1541 - Lumbar, thoracic, and cervical fusion devices including less invasive instrumentation; lumbar and cervical artificial discs
• Company 1542 - Lumbar spine motion preservation via dynamic stabilization utilizing a semi-rigid rod and screw system
• Company 1543 - 1-Stand-alone anterior lumbar IBF device and 2-Stand-alone cervical IBF device
• Company 1544 - Compliant artificial lumbar disc with graduated modulus for restoration of normal spine biomechanics/enhanced durability
• Company 1545 - 1-Synthetic alternatives to autograft/cadaver-based bone material, 2-Surgical hemostat as an adherent matrix/impermeable barrier to blood flow, 3-Bone augmentation material for injections in osteoporotic spines to treat vertebral compression fractures
• Company 1546 - Orthopeutics, LP introduces Intrabrace a new non-surgical, injectable treatment for resisting spinal curvature in scoliosis.
• Company 1547 - Bioactive synthetic bone graft substitute that is osteostimulative, osteoconductive, antimicrobial, and hemostatic
• Company 1548 - Next-generation fusion, motion sparing, and minimally invasive spinal implant products
• Company 1549 - Minimally invasive fusion system
• Company 1550 - Fluidjet devices for open and MIS fusion, discectomy, artificial nucleus, and artificial disc procedures
• Company 1551 - Osteogenica - bone marrow concentration system
• Company 1552 - Dascor Arthroplasty System, spinal implants technology
• Company 1553 - BioDisc, a nucleus replacement product based on an injectable, flexible, and durable protein hydrogel technology
• Company 1554 - Second-generation, viscoelastic artificial disc restoring native function to the spine
• Company 1555 - Three-dimensional surgical visualization technologies and expanding portfolio for digital surgical environment and digital healthcare network
• Company 1556 - Real-time disposable stereotactic navigation devices for biopsy/targeted therapy compatible with CT, fluoroscopy, and MRI
• Company 1557 - Minimally invasive cancer therapy using Magnetically Energized (ME) Thermotherapy
• Company 1558 - Magneto-Optical Enantiomeric Detection (MOPED) for real-time, non-contact analysis of chiral pharmaceuticals
• Company 1559 - First noninvasive, transcutaneous sensor array that continuously monitors peripheral circulation and/or core body temperature
• Company 1560 - Disposable balloon cervical dilator for improved uterine access that decreases pain, avoids tearing and perforations
• Company 1561 - Biological therapeutics for the treatment of neurological disorders including: Alzheimer's disease, epilepsy, Huntington's disease, Parkinson's disease, and neuropathic pain
• Company 1562 - Complete pre-configured system for implementing minimized cardiopulmonary bypass
• Company 1563 - Catheter-based sealing of heart defects associated with stroke, migraine headaches, and other brain attacks
• Company 1564 - Technology for imaging peripheral nerves in regional anesthesiology, pain management, and other markets
• Company 1565 - Nanomagnetic particles enabling controlled drug delivery and elution for drug targeting and medical device applications
• Company 1566 - MRI-compatible, precision- guided laser therapy for the treatment of brain tumors
• Company 1567 - Implantable blood pump with magnetic levitation technology for patients suffering from heart failure
• Company 1568 - Virtual Bone Biopsy MRI scanner add-on, allowing noninvasive imaging of bone microstructure for osteoporosis monitoring
• Company 1569 - Mazor Robotics' Renaissance(TM) Surgical Guidance System is transforming spine surgery from freehand procedures to highly-accurate, state-of-the-art operations that raise the standard of care with better clinical outcomes
• Company 1570 - Nanotechnology-based cancer therapy with contactless activation of tumor-specific nano-particles, adaptable to all solid tumors
• Company 1571 - Point-of-care platform technology for assessing risk of cardiovascular disease and renal dysfunction
• Company 1572 - Continuous blood gas monitoring and cardiac output measurement for the intensive care unit
• Company 1573 - Non-blood contacting, active implantable direct cardiac compression device for the treatment of CHF
• Company 1574 - Augmented reality simulators that train surgeons in the skills required for minimally invasive surgery
• Company 1575 - Continuous, non-invasive glucose monitor for tight glycemic control at the hospital and at home
• Company 1576 - ERBLAN MIS Surgical Devices allow safe entry into virtually any actual or potential anatomical space
• Company 1577 - Technology that non-invasively measures/monitors mechanical heart function and disease utilizing a disposable brachial cuff
• Company 1578 - Endovenous ablation system for varicose veins with 1320 nm CoolTouch laser
• Company 1579 - Micro-porous ceramic wound treatment device that creates optimal conditions for normal wound healing
• Company 1580 - Direct, real-time vision through flowing blood to guide therapy inside the heart and vessels
• Company 1581 - Cath lab solution providing rapid onset of circulatory support in patients with acute heart failure
• Company 1582 - Magnesium-based compound that will attach bone to bone and ligaments and tendons to bone
• Company 1583 - AepEX auditory evoked potential depth of anesthesia monitor and aepEX-Fusion servo-controlled anesthesia delivery system
• Company 1584 - Posterior dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion
• Company 1585 - Site-specific biological and drug delivery
• Company 1586 - HistoScanning(TM) is an innovative imaging-based modality available in the Tissue Characterization market; the only one offering accurate 3D detection and localization of cancer lesions
• Company 1587 - Non-irritating dry electrodes now enabling long-term cardiac monitoring
• Company 1588 - Non-incisional female sterilization
• Company 1589 - Biopharmaceuticals targeting osteo-renal indications, including the complications of chronic kidney disease and dialysis, bone and cartilage repair and regeneration, and general dental and oral care
• Company 1590 - Portable, compact, easy-to-use automated external defibrillators with full energy delivery and complete resuscitation solutions
• Company 1591 - Rapid, point-of-care in vitro diagnostics
• Company 1592 - Endoscopy systems allowing physicians to see very small, early-stage cancer and subtle pre-cancerous lesions
• Company 1593 - Surgical instruments employing thermal welding technology to seal and cut tissue
• Company 1594 - Minimally invasive disc replacement for chronic back pain
• Company 1595 - A smart, communicating cigarette case, online support, and daily e-mails delivering an effective stop-smoking method
• Company 1596 - A wireless personal emergency alert system that integrates with, and enhances, existing implanted medical devices
• Company 1597 - Artificial total intervertebral disc capable of normal physiological movement and weight loading
• Company 1598 - Catheters designed to diagnose, terminate, and treat cardiac arrhythmia during EP and ablation procedures
• Company 1599 - Conservative Motion Preservation technology including minimally invasive facet joint replacement
• Company 1600 - BioSilicon, nano-structured porous silicon for applications in drug delivery, diagnostics, tissue engineering, and orthopedics
• Company 1601 - System that prevents embolic events by removing plaque and thrombus found in diseased arteries
• Company 1602 - Bioresorbable polymer implants for use in a variety of orthopedics and spine surgical applications
• Company 1603 - Liposomal formulation of recombinant IL-2 for use as chemotherapy or cancer vaccine adjuvant
• Company 1604 - Helical stent providing enhanced abilities and flexibilities in drug delivery, scaffolding, and embolic protection
• Company 1605 - Trabectome, an FDA-cleared, minimally invasive medical device technology for the treatment of open angel glaucoma
• Company 1606 - ClearSolution represents the next wave in integrated, intra and interoperative physiologic monitoring. ClearSolution enables a non-invasive, wireless solution for continuous, multi-modal patient monitoring for image-facilitated minimally invasive surgery, improved CAD detection, and remote patient monitoring.
• Company 1607 - Prevention of scarring caused by disease, medical intervention, or trauma via a beta emitting biopolymer
• Company 1608 - Noninvasive, site-specific drug delivery technology to deliver compounds to the posterior segments of the eye
• Company 1609 - Real-time, CT-guided, robotically controlled needle drivers for minimally invasive cancer therapy
• Company 1610 - Automated, continual blood glucose monitoring for critically ill patients
• Company 1611 - Molecular diagnostics based on patented, standardized, next-generation, multi-gene expression (StaRT-PCR) products and high margin services
• Company 1612 - THERMOCEPS - a handheld, wireless device that stops bleeding during surgical procedures using focused, thermal coagulation
• Company 1613 - Interventional catheter system for the mechanical recanalization of arterial chronic total occlusions quickly and reliably
• Company 1614 - Portable automated critical care neuro instruments using advanced digital signal processing technology
• Company 1615 - Monitor for autonomic nervous system displaying sympathovagal balance in real-time for diabetes/ anesthesia/cardiology applications
• Company 1616 - Branched endografts for aortic disease
• Company 1617 - Next-generation biomaterials using bioactive-ceramics technology platform
• Company 1618 - Immunodiagnostics of placental recombinant markers to screen the risk of preeclampsia, preterm delivery, and IUGR
• Company 1619 - Methods for eyebrow lifting, non-thermal loading of degradable matrices, and degradable implants
• Company 1620 - Non-invasive modality for the treatment of insulin resistance/diabetic neuropathy
• Company 1621 - Minimally invasive needle biosensor for in vivo glucose or lactate monitoring of intensive care patients
• Company 1622 - P-15: a small peptide attachment factor for bone formation in orthopedics
• Company 1623 - MIST Therapy using non-contact ultrasound to stimulate healthy cells allowing chronic wounds to heal
• Company 1624 - Arthroscopic surgical devices
• Company 1625 - Electronic device that closes the gap between drugs and surgery in osteoarthritis of the knee
• Company 1626 - Cell-based therapy products for the treatment of heart failure secondary to myocardial infarction
• Company 1627 - A five-carbon carbohydrate that increases cellular energy, improving cardiovascular health and tissue function
• Company 1628 - The most advanced Infrared Light Therapy technology available that is clinically proven to reduce sports injury healing time by >60%, with additional applications for oral tissue and migraines
• Company 1629 - Next-generation non-vascular interventional pulmonary and gastrointestinal stenting technology
• Company 1630 - A revolutionary device that will facilitate broad implementation of extracorporeal CO2 removal and oxygen supplementation resulting in the avoidance of airway intubation, sedation, and invasive mechanical ventilation
• Company 1631 - Intravascular temperature management systems and catheters for cardiac and neuro intensive care patients
• Company 1632 - Implantable devices for the endovascular treatment of hemorrhagic stroke
• Company 1633 - Ultrasound catheters for targeted thermal ablation of tumors

* Corporate License allows for multi-user and/or enterprise wide access.